UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
xANNUAL REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the fiscal year ended December 31, 2020
OR
¨TRANSITION REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
Commission file number 1-13412
Hudson Technologies, Inc.
(Exact name of registrant as specified in its charter)
New
York |
13-3641539 |
(State
or Other Jurisdiction of Incorporation or Organization) |
(I.R.S.
Employer Identification No.) |
|
|
P.O. Box
1541 |
|
One
Blue Hill Plaza |
|
Pearl
River, New York |
10965 |
(Address
of Principal Executive Offices) |
(Zip
Code) |
Registrant’s telephone number, including area code (845)
735-6000
Securities registered pursuant to Section 12(b) of the
Act:
Title
of Each Class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which
registered |
Common
stock, $0.01 par value |
|
HDSN |
|
The
NASDAQ Stock Market LLC (NASDAQ Capital Market) |
Securities registered pursuant to Section 12(g) of the
Act: None
Indicate
by check mark if the registrant is a well-known seasoned issuer, as
defined in Rule 405 of the Securities Act ¨ Yes x No
Indicate
by check mark if the registrant is not required to file reports
pursuant to Section 13 or 15(d) of the Exchange Act
¨ Yes x No
Indicate
by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing
requirements for the past 90 days. x Yes ¨ No
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during
the preceding 12 months (or for such shorter period that the
registrant was required to submit such files). x Yes ¨ No
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company or an emerging growth company. See the
definitions of “large accelerated filer”, “accelerated filer”,
“smaller reporting company” and “emerging growth company” in
Rule 12b-2 of the Exchange Act:
Large
accelerated filer |
¨ |
Accelerated
filer |
¨ |
|
|
|
|
Non-accelerated
filer |
x |
Smaller
reporting company |
x |
|
|
|
|
|
|
Emerging
growth company |
¨ |
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.
¨
Indicate
by check mark whether the registrant has filed a report on and
attestation to its management’s assessment of the effectiveness of
its internal control over financial reporting under Section
404(b) of the Sarbanes-Oxley
Act (15 U.S.C. 7262(b)) by the registered public accounting firm
that prepared or issued its audit report. ¨
Indicate
by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Act). ¨ Yes x No
The aggregate market value of registrant’s common stock held by
non-affiliates at June 30, 2020 was approximately $37,335,882.
As of March 1, 2021, there were 43,347,887 shares of the
registrant’s common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE:
Portions
of the Registrant's Proxy Statement for its Annual Meeting of
Stockholders to be held on June 10, 2021, are incorporated
by reference in Part III of this Report. Except as expressly
incorporated by reference, the Registrant's Proxy Statement shall
not be deemed to be part of this Form 10-K.
Hudson Technologies, Inc.
Index
Part I
Item 1. Business
General
Hudson Technologies, Inc. (“Hudson”, the “Company”),
incorporated under the laws of New York on January 11, 1991,
is a refrigerant services company providing innovative solutions to
recurring problems within the refrigeration industry. Hudson has
proven, reliable programs that meet customer refrigerant needs by
providing environmentally sustainable solutions from initial sale
of refrigerant gas through recovery, reclamation and reuse, peak
operating performance of equipment through energy efficiency and
emergency air conditioning and refrigeration system repair, to
final refrigerant disposal and carbon credit trading.
The Company’s operations consist of one reportable segment. The
Company's products and services are primarily used in commercial
air conditioning, industrial processing and refrigeration systems,
and include refrigerant and industrial gas sales, refrigerant
management services consisting primarily of reclamation of
refrigerants and RefrigerantSide® Services performed at a
customer's site, consisting of system decontamination to remove
moisture, oils and other contaminants. In addition, the Company’s
SmartEnergy OPS® service is a web-based real time continuous
monitoring service applicable to a facility’s refrigeration systems
and other energy systems. The Company’s Chiller Chemistry® and
Chill Smart® services are also predictive and diagnostic service
offerings. As a component of the Company’s products and services,
the Company also participates in the generation of carbon offset
projects. The Company operates principally through its wholly-owned
subsidiary, Hudson Technologies Company, and Aspen Refrigerants
(“Aspen” or “ARI”), a division of Hudson Technologies Company.
Unless the context requires otherwise, references to the “Company”,
“Hudson”, “we", “us”, “our”, or similar pronouns refer to Hudson
Technologies, Inc. and its subsidiaries.
The Company's executive offices are located at One Blue Hill Plaza,
Pearl River, New York and its telephone number is (845) 735-6000.
The Company maintains a website at www.hudsontech.com, the
contents of which are not incorporated into this filing.
Industry Background
The Company participates in an industry that is highly regulated,
and changes in the regulations affecting our business could affect
our operating results. Currently the Company purchases virgin,
hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”)
refrigerants and reclaimable, primarily HCFC, HFC and
chlorofluorocarbon (“CFC”) refrigerants from suppliers and its
customers. Effective January 1, 1996, the Clean Air Act, as
amended (the “Act”) prohibited the production of virgin CFC
refrigerants and limited the production of virgin HCFC
refrigerants. Effective January 2004, the Act further limited
the production of virgin HCFC refrigerants and federal regulations
were enacted which established production and consumption
allowances for HCFC refrigerants and which imposed limitations on
the importation of certain virgin HCFC refrigerants. Under the Act,
production of certain virgin HCFC refrigerants was phased out on
December 31, 2019 and production of all virgin HCFC
refrigerants is scheduled to be phased out by 2030.
The Act, and the federal regulations enacted under authority of the
Act, have mandated and/or promoted responsible use practices in the
air conditioning and refrigeration industry, which are intended to
minimize the release of refrigerants into the atmosphere and
encourage the recovery and re-use of refrigerants. The Act
prohibits the venting of CFC, HFC and HCFC refrigerants, and
prohibits and/or phases down the production of CFC and HCFC
refrigerants.
The Act also mandates the recovery of CFC and HCFC refrigerants and
also promotes and encourages re-use and reclamation of CFC and HCFC
refrigerants. Under the Act, owners, operators and companies
servicing cooling equipment utilizing CFC and HCFC refrigerants are
responsible for the integrity of the systems regardless of the
refrigerant being used. In November 2016, the EPA issued a
final rule extending these requirements to HFCs and to certain
other refrigerants that are approved by the EPA as alternatives for
CFC and HCFC refrigerants (the “608 Rule”).
HFC refrigerants are used as substitutes for CFC and HCFC
refrigerants in certain applications. As a result of the increasing
restrictions and limitations on the production and use of CFC and
HCFC refrigerants, various sectors of the air conditioning and
refrigeration industry have been replacing or modifying equipment
that utilize CFC and HCFC refrigerants and have been transitioning
to equipment that utilize HFC refrigerants and hydrofluoro-olefins
(“HFO”). HFC refrigerants are not ozone depleting chemicals and are
not currently regulated under the Act. However, certain HFC
refrigerants are highly weighted greenhouse gases that are believed
to contribute to global warming and climate change and, as a
result, are now subject to various state regulations relating to
the sale, use and emissions of HFC refrigerants. The Company
expects that HFC refrigerants eventually will be replaced by HFOs
or other types of products with lower global warming
potentials.
In October 2016, more than 200 countries, including the United
States, agreed to amend the Montreal Protocol to phase down
production of HFCs by 85% by 2047. The amendment establishes
timetables for all developed and developing countries to freeze and
then reduce production and use of HFCs, with the first reductions
by developed countries in 2019. The amendment became effective
January 1, 2019 as more than twenty countries have ratified
the amendment.
In December 2020, legislation was enacted in the United States
that will require the phasedown of virgin production of HFCs, which
will also increase opportunities for reclamation of HFCs.
Products and Services
Sustainability
The Company provides a complete offering of refrigerant management
services, which primarily include reclamation of refrigerants,
laboratory testing through the Company’s laboratory, which has been
certified by the Air Conditioning, Heating and Refrigeration
Institute (“AHRI”), and banking (storage) services tailored to
individual customer requirements. The Company also separates
“crossed” (i.e. commingled) refrigerants and provides re-usable
cylinder refurbishment and hydrostatic testing services.
From its inception, the Company has sold refrigerants, and has
provided refrigerant reclamation and refrigerant management
services that are designed to recover and reuse refrigerants,
thereby protecting the environment from release of refrigerants to
the atmosphere and the corresponding ozone depletion and global
warming impact. The reclamation process allows the refrigerant to
be re-used thereby eliminating the need to destroy or manufacture
additional refrigerant and eliminating the corresponding impact to
the environment associated with the destruction and
manufacturing. The Company believes it is the largest
refrigerant reclaimer in the United States. In addition, the
Company is pursuing potential opportunities for the creation and
monetization of verified emission reductions.
The Company has also created alternative solutions to reactive and
preventative maintenance procedures that are performed on
commercial and industrial refrigeration systems. These
services, known as RefrigerantSide® Services, complement the
Company’s refrigerant sales and refrigerant reclamation and
management services. The Company has also developed
SmartEnergy OPS® that identifies inefficiencies in the operation of
air conditioning and refrigeration systems and assists companies to
improve the energy efficiency of their systems and save operating
costs and improve system reliability.
Refrigerant and Industrial Gas Sales
The Company sells reclaimed and virgin (new) refrigerants to a
variety of customers in the air conditioning and refrigeration
industry. The Company continues to sell reclaimed CFC based
refrigerants, which are no longer manufactured. Virgin refrigerants
are purchased by the Company from several suppliers and resold by
the Company. Additionally, the Company regularly purchases used or
contaminated refrigerants, from many different sources, which
refrigerants are then reclaimed using the Company's high speed
proprietary reclamation equipment, its proprietary Zugibeast®
system, and then are resold by the Company.
The Company also sells industrial gases to a variety of industry
customers, predominantly to users in or involved with the US
Military. In July 2016, the Company was awarded, as
prime contractor, a five-year fixed price contract, including a
five-year renewal option, awarded to it by the United States
Defense Logistics Agency (“DLA”) for the management and supply of
refrigerants, compressed gases, cylinders and related items to US
Military commands and installations, Federal civilian agencies and
foreign militaries. Primary users include the US Army, Navy,
Air Force, Marine Corps and Coast Guard.
Carbon Offset Projects
CFC refrigerants are ozone depleting substances and are also highly
weighted greenhouse gases that contribute to global warming and
climate change. The destruction of CFC refrigerants may be eligible
for verified emission reductions that can be converted and
monetized into carbon offset credits, which then can be traded in
the emerging carbon offset markets. The Company is pursuing
opportunities to acquire CFC refrigerants and is developing
relationships within the emerging environmental markets in order to
develop opportunities for the creation and monetization of verified
emission reductions from the destruction of CFC refrigerants.
In October 2015, the American Carbon Registry (“ACR”)
established a methodology to provide, among other things, a
quantification framework for the creation of carbon offset credits
for the use of certified reclaimed HFC refrigerants. The Company is
pursuing opportunities to acquire HFC refrigerants and is
developing relationships within the emerging environmental markets
in order to develop opportunities for the creation and monetization
of verified emission reductions from the reclamation of HFC
refrigerants.
RefrigerantSide® Services
The Company provides decontamination and recovery services that are
performed at a customer's site through the use of portable, high
volume, high-speed proprietary equipment, including the patented
Zugibeast® system. Certain of these RefrigerantSide®
Services, which encompass system decontamination, and refrigerant
recovery and reclamation, are also proprietary and are covered by
process patents.
In addition to the decontamination and recovery services previously
described, the Company also provides predictive and diagnostic
services for its customers. The Company offers diagnostic
services that are intended to predict potential problems in air
conditioning and refrigeration systems before they occur. The
Company’s Chiller Chemistry® offering integrates several fluid
tests of an operating system and the corresponding laboratory
results into an engineering report providing its customers with an
understanding of the current condition of the fluids, the cause for
any abnormal findings and the potential consequences if the
abnormal findings are not remediated. Fluid Chemistry®, an
abbreviated version of the Company’s Chiller Chemistry® offering,
is designed to quickly identify systems that require further
examination.
The Company has also been awarded several US patents for its
SmartEnergy OPS®, which is a system for measuring, modifying and
improving the efficiency of energy systems, including air
conditioning and refrigeration systems, in industrial and
commercial applications. This service is a web-based real time
continuous monitoring service applicable to a facility’s chiller
plant systems. The SmartEnergy OPS® offering enables customers to
monitor and improve their chiller plant performance and proactively
identify and correct system inefficiencies. SmartEnergy OPS® is
able to identify specific inefficiencies in the operation of
chiller plant systems and, when used with Hudson’s RefrigerantSide
® Services, can increase the efficiency of the operating
systems thereby reducing energy usage and costs. Improving the
system efficiency reduces power consumption thereby directly
reducing CO 2 emissions at the power plants or
onsite. Lastly, the Company’s ChillSmart® offering,
which combines the system optimization with the Company’s Chiller
Chemistry ® offering, provides a snapshot of a packaged
chiller’s operating efficiency and health. ChillSmart® provides a
very effective predictive maintenance tool and helps our customers
to identify the operating chillers that cause higher operating
costs.
The Company’s engineers who developed and support SmartEnergy OPS®
are recognized as Energy Experts and Qualified Best Practices
Specialists by the United States Department of Energy (“DOE”) in
the areas of Steam and Process Heating under the DOE “Best
Practices” program, and are the Lead International Energy Experts
for steam, chillers and refrigeration systems for the United
Nations Industrial Development Organization (“UNIDO”). The
Company’s staff have trained more than 4,000 industrial plant
personnel in the US and internationally and have developed, and are
currently delivering, training curriculums in 12 different
countries. The Company’s staff have completed more than 200
industrial ESAs in the US and internationally.
Strategic Alliances
The Company purchases refrigerants from a variety of manufacturers,
wholesalers, distributors, bulk gas brokers and from other sources
within the air conditioning, refrigeration and automotive
aftermarket industries, and on corresponding demand for
refrigerants.
Suppliers
The Company purchases refrigerants from a variety of manufacturers,
wholesalers, distributors, bulk gas brokers and from other sources
within the air conditioning, refrigeration and automotive
aftermarket industries, and on corresponding demand for
refrigerants.
Customers
The Company provides its products and services to commercial,
industrial and governmental customers, as well as to refrigerant
wholesalers, distributors, contractors and to refrigeration
equipment manufacturers. Agreements with larger customers generally
provide for standardized pricing for specified services. The
Company generates sales by customer purchase order on a real-time
basis and therefore does not carry a backlog of sales.
For the year ended December 31, 2020, one customer accounted
for 14% of the Company’s revenues and at December 31, 2020,
there were $2.9 million of outstanding receivables from this
customer. For the year ended December 31, 2019, one customer
accounted for 14% of the Company’s revenues and at
December 31, 2019, there were $1.8 million of outstanding
receivables from this customer.
Marketing
Marketing programs are conducted through the efforts of the
Company's executive officers, Company sales personnel, and third
parties. Hudson employs various marketing methods, including direct
mailings, telemarketing, technical bulletins, in-person
solicitation, print advertising, response to quotation requests and
the internet through the Company’s websites (www.hudsontech.com
and www.ASPENRefrigerants.com). Information on the Company's
websites are not part of this report.
The Company's sales personnel are compensated on a combination of a
base salary and commission. The Company's executive officers devote
significant time and effort to customer relationships.
Competition
The Company competes primarily on the basis of the performance of
its proprietary high volume, high-speed equipment used in its
operations, the breadth of services offered by the Company,
including proprietary RefrigerantSide® Services and other on-site
services, and price, particularly with respect to refrigerant
sales.
The Company competes with numerous regional and national companies
that market reclaimed and virgin refrigerants and provide
refrigerant reclamation services. Certain of these competitors may
possess greater financial, marketing, distribution and other
resources for the sale and distribution of refrigerants than the
Company.
Hudson's RefrigerantSide® Services provide solutions to certain
problems within the refrigeration industry and, as such, the demand
and market acceptance for these services are subject to
uncertainty. Competition for these services primarily consists of
traditional methods of solving the industry's problems. The
Company’s marketing strategy is to educate the marketplace that its
alternative solutions are available and that RefrigerantSide®
Services are superior to traditional methods.
Risk Management
The Company carries insurance coverage that it considers sufficient
to protect the Company's assets and operations. The Company
attempts to operate in a professional and prudent manner and to
reduce potential liability risks through specific risk management
efforts, including ongoing employee training.
The refrigerant industry involves potentially significant risks of
statutory and common law liability for environmental damage and
personal injury. The Company, and in certain instances, its
officers, directors and employees, may be subject to claims arising
from the Company's on-site or off-site services, including the
improper release, spillage, misuse or mishandling of refrigerants
classified as hazardous or non-hazardous substances or materials.
The Company may be held strictly liable for damages, which could be
substantial, regardless of whether it exercised due care and
complied with all relevant laws and regulations.
Hudson maintains environmental impairment insurance of $10,000,000
per occurrence, and $10,000,000 annual aggregate, for events
occurring subsequent to November 1996.
Government Regulation
The business of refrigerant and industrial gas sales, reclamation
and management is subject to extensive, stringent and frequently
changing federal, state and local laws and substantial regulation
under these laws by governmental agencies, including the EPA, the
United States Occupational Safety and Health Administration
(“OSHA”) and the United States Department of Transportation
(“DOT”).
Among other things, these regulatory authorities impose
requirements which regulate the handling, packaging, labeling,
transportation and disposal of hazardous and non-hazardous
materials and the health and safety of workers, and require the
Company and, in certain instances, its employees, to obtain and
maintain licenses in connection with its operations. This extensive
regulatory framework imposes significant compliance burdens and
risks on the Company.
Hudson and its customers are subject to the requirements of the
Act, and the regulations promulgated thereunder by the EPA, which
make it unlawful for any person in the course of maintaining,
servicing, repairing, and disposing of air conditioning or
refrigeration equipment, to knowingly vent or otherwise release or
dispose of ozone depleting substances, and non-ozone depleting
substitutes, used as refrigerants.
Pursuant to the Act, reclaimed refrigerant must satisfy the same
purity standards as newly manufactured, virgin refrigerants in
accordance with standards established by AHRI prior to resale to a
person other than the owner of the equipment from which it was
recovered. The EPA administers a certification program pursuant to
which applicants certify to reclaim refrigerants in compliance with
AHRI standards. The Company is one of only four certified
refrigerant testing laboratories in the United States under AHRI’s
laboratory certification program, which is a voluntary program that
certifies the ability of a laboratory to test refrigerant in
accordance with the AHRI 700 standard. In addition, the EPA has
established a mandatory certification program for air conditioning
and refrigeration technicians. Hudson's technicians have applied
for or obtained such certification.
The Company may also be subject to regulations adopted by the EPA
which impose reporting requirements arising out of the importation
of certain HCFCs, and arising out of the importation, purchase,
production, use and/or emissions of certain greenhouse gases,
including HFCs.
The Company is also subject to regulations adopted by the DOT which
classify most refrigerants and industrial gases handled by the
Company as hazardous materials or substances and imposes
requirements for handling, packaging, labeling and transporting
refrigerants and which regulate the use and operation of the
Company’s commercial motor vehicles used in the Company’s
business.
The Resource Conservation and Recovery Act of 1976, as amended
("RCRA"), requires facilities that treat, store or dispose of
hazardous wastes to comply with certain operating standards. Before
transportation and disposal of hazardous wastes off-site,
generators of such waste must package and label their shipments
consistent with detailed regulations and prepare a manifest
identifying the material and stating its destination. The
transporter must deliver the hazardous waste in accordance with the
manifest to a facility with an appropriate RCRA permit. Under RCRA,
impurities removed from refrigerants consisting of oils mixed with
water and other contaminants are not presumed to be hazardous
waste.
The Emergency Planning and Community Right-to-Know Act of 1986, as
amended, requires the annual reporting by the Company of Emergency
and Hazardous Chemical Inventories (Tier II reports) to the various
states in which the Company operates and requires the Company to
file annual Toxic Chemical Release Inventory Forms with the
EPA.
The Comprehensive Environmental Response, Compensation and
Liability Act of 1980 (“CERCLA”), establishes liability for
clean-up costs and environmental damages to current and former
facility owners and operators, as well as persons who transport or
arrange for transportation of hazardous substances. Almost all
states have similar statutes regulating the handling and storage of
hazardous substances, hazardous wastes and non-hazardous wastes.
Many such statutes impose requirements that are more stringent than
their federal counterparts. The Company could be subject to
substantial liability under these statutes to private parties and
government entities, in some instances without any fault, for
fines, remediation costs and environmental damage, as a result of
the mishandling, release, or existence of any hazardous substances
at any of its facilities.
The Occupational Safety and Health Act of 1970, as amended mandates
requirements for a safe work place for employees and special
procedures and measures for the handling of certain hazardous and
toxic substances. State laws, in certain circumstances, mandate
additional measures for facilities handling specified materials.
The Company is also subject to regulations adopted by the
California Air Resources Board which impose certain reporting
requirements arising out of the reclamation and sale of
refrigerants that takes place within the State of California.
The Company believes that it is in material compliance with all
applicable regulations material to its business operations.
Quality Assurance & Environmental Compliance
The Company utilizes in-house quality and regulatory compliance
control procedures. Hudson maintains its own analytical testing
laboratories, which are AHRI certified, to assure that reclaimed
refrigerants comply with AHRI purity standards and employs portable
testing equipment when performing on-site services to verify
certain quality specifications. The Company employs twelve persons
engaged full-time in quality control and to monitor the Company's
operations for regulatory compliance.
Human Capital Resources
On March 8, 2021, the Company had 221 full time employees including
air conditioning and refrigeration technicians, chemists,
engineers, sales and administrative personnel. None of the
Company's employees are represented by a union. The Company
believes it has good relations with its employees.
Patents and Proprietary Information
The Company holds several U.S. and foreign patents, as well as
pending patent applications, related to certain RefrigerantSide®
Services and supporting systems developed by the Company for
systems and processes for measuring and improving the efficiency of
refrigeration systems, and for certain refrigerant recycling and
reclamation technologies. These patents will expire between January
2023 and July 2035.
There can be no assurance as to the breadth or degree of protection
that patents may afford the Company, that any patent applications
will result in issued patents or that patents will not be
circumvented or invalidated. Technological development in the
refrigerant industry may result in extensive patent filings and a
rapid rate of issuance of new patents. Although the Company
believes that its existing patents and the Company's equipment do
not and will not infringe upon existing patents or violate
proprietary rights of others, it is possible that the Company's
existing patent rights may not be valid or that infringement of
existing or future patents or violations of proprietary rights of
others may occur. In the event the Company's equipment or processes
infringe, or are alleged to infringe, patents or other proprietary
rights of others, the Company may be required to modify the design
of its equipment or processes, obtain a license or defend a
possible patent infringement action. There can be no assurance that
the Company will have the financial or other resources necessary to
enforce or defend a patent infringement or proprietary rights
violation action or that the Company will not become liable for
damages.
The Company also relies on trade secrets and proprietary know-how,
and employs various methods to protect its technology. However,
such methods may not afford complete protection and there can be no
assurance that others will not independently develop such know-how
or obtain access to the Company's know-how, concepts, ideas and
documentation. Failure to protect its trade secrets could have a
material adverse effect on the Company.
SEC Filings
The Company makes available on its internet website copies of its
Annual Report on Form 10-K, Quarterly Reports on
Form 10-Q, Current Reports on Form 8-K, and amendments
thereto, as soon as reasonably practicable after they are filed
with the Securities and Exchange Commission.
Item 1A. Risk Factors
There are many important factors, including those discussed below
(and above as described under “Patents and Proprietary
Information”), that have affected, and in the future could affect
Hudson’s business including, but not limited to, the factors
discussed below, which should be reviewed carefully together with
the other information contained in this report. Some of the factors
are beyond Hudson’s control and future trends are difficult to
predict.
Risks Related to Business Strategy and Operations
Our existing and future debt obligations could impair our
liquidity and financial condition.
Our existing credit facilities, consisting of an asset-based
lending facility of up to $60 million from Wells Fargo Bank,
National Association (“Wells Fargo Bank”) and a term loan of $85
million from funds advised by FS Investments, are secured by
substantially all of our assets and the Wells Fargo Bank facility
contains formulas that limit the amount of our future borrowings
under that facility. Moreover, the terms of our credit facilities
also include financial and negative covenants that, among other
things, may limit our ability to incur additional indebtedness. If
we violate any loan covenants and do not obtain a waiver from our
lenders, our indebtedness under the credit facilities would become
immediately due and payable, and the lenders could foreclose on
their security, which could materially adversely affect our
business and future financial condition and could require us to
curtail or otherwise cease our existing operations.
Our revenues, results of operations and cash flows could be
materially and adversely affected by changes in commodity
prices.
Our revenues, results of operations and cash flows are affected by
market prices for refrigerant gases. Commodity prices generally are
affected by a wide range of factors beyond our control, including
weather, seasonality, the availability and adequacy of supply,
government regulation and policies and general political and
economic conditions. We are exposed to fluctuating commodity prices
as the result of our inventory of various refrigerant gases. At any
time, our inventory levels may be substantial. During 2019, there
were $9.2 million of non-cash charges for inventory adjustments of
our refrigerant gases due to a decline in refrigerant gas prices.
Further declines in refrigerant gas prices could result in
additional inventory adjustments and impairment charges. We have
processes in place to monitor exposures to these risks and engage
in strategies to manage these risks. If these controls and
strategies are not successful in mitigating our exposure to these
fluctuations, we could be materially and adversely affected.
Our business has been impacted by the COVID-19
pandemic.
The public health crisis caused by the COVID-19 pandemic and
the measures being taken by governments, businesses, including us,
and the public at large to limit COVID-19's spread may have
certain negative impacts on our business including, without
limitation, the following:
• |
We
may experience a further decrease in sales due to the COVID-19
pandemic. In particular, sales of our products to customers, such
as schools, offices and government facilities, which have shut
down, have been negatively impacted. If the COVID-19
pandemic intensifies and expands geographically, its negative
impacts on our sales and collectability of receivables could be
more prolonged and may become more severe. |
|
|
• |
Although
we have not experienced this during 2020, future potential
disruptions in supply chains may place constraints on our ability
to source refrigerants, which may increase our processing
costs. |
|
|
• |
Governmental
authorities in the United States and throughout the world may
continue to increase or impose new income taxes or indirect taxes,
or revise interpretations of existing tax rules and
regulations, as a means of financing the costs of stimulus and
other measures enacted or taken, or that may be enacted or taken in
the future, to protect populations and economies from the impact of
the COVID-19 pandemic. Such actions could have an adverse effect on
our results of operations and cash flows. |
• |
As a
result of the COVID-19 pandemic, including related governmental
guidance or directives, we have required most office-based
employees to work remotely. We may experience reductions in
productivity and disruptions to our business routines while our
remote work policy remains in place. |
|
|
• |
Actions
we have taken or may take, or decisions we have made or may make,
as a consequence of the COVID-19 pandemic may result in legal
claims or litigation against us. |
Any of the negative impacts of the COVID-19 pandemic, including
those described above, alone or in combination with others, may
have a material adverse effect on our results of operations,
financial condition and cash flows. The full extent to which
the COVID-19 pandemic will negatively affect our results of
operations, financial condition and cash flows will depend on
future developments that are highly uncertain and cannot be
predicted, including the scope and duration of the pandemic and
actions taken by governmental authorities and other third parties
in response to the pandemic.
We may need additional financing to satisfy our future capital
requirements, which may not be readily available to
us.
Our capital requirements may be significant in the future. We may
incur additional expenses in the development and implementation of
our operations. Due to fluctuations in the price, demand and
availability of new refrigerants, our existing credit facility with
Wells Fargo Bank that expires in December 2022 may not in the
future be sufficient to provide all of the capital that we need to
acquire and manage our inventories of new refrigerant. As a result,
we may be required to seek additional equity or debt financing in
order to develop our RefrigerantSide® Services business, our
refrigerant sales business and our other businesses. We have no
current arrangements with respect to, or sources of, additional
financing other than our existing credit facility and term loan.
There can be no assurance that we will be able to obtain any
additional financing on terms acceptable to us or at all. Our
inability to obtain financing, if and when needed, could materially
adversely affect our business and future financial condition and
could require us to curtail or otherwise cease our existing
operations.
Adverse weather or economic downturn could adversely impact
our financial results.
Our business could be negatively impacted by adverse weather or
economic downturns. Weather is a significant factor in determining
market demand for the refrigerants sold by us, and to a lesser
extent, our RefrigerantSide® Services. Unusually cool temperatures
in the spring and summer tend to depress demand for, and price of,
refrigerants we sell. Protracted periods of cooler than normal
spring and summer weather could result in a substantial reduction
in our sales which could adversely affect our financial position as
well as our results of operations. An economic downturn could cause
customers to postpone or cancel purchases of the Company’s products
or services. Either or both of these conditions could have severe
negative implications to our business that may exacerbate many of
the risk factors we identified in this report but not limited, to
the following:
Liquidity
These conditions could reduce our liquidity, which could have a
negative impact on our financial condition and results of
operations.
Demand
These conditions could lower the demand and/or price for our
product and services, which would have a negative impact on our
results of operations.
Financial Covenants
These conditions could impact our ability to meet our loan
covenants which, if we are unable to obtain a waiver from our
lenders, could materially adversely affect our business and future
financial condition and could require us to curtail or otherwise
cease our existing operations.
Our business is impacted by customer
concentration.
In July 2016, we were awarded, as prime contractor, a
five-year fixed price contract, including a five-year renewal
option, by the United States Defense Logistics Agency (“DLA”) for
the management and supply of refrigerants, compressed gases,
cylinders and related items to US Military commands and
installations, Federal civilian agencies and foreign militaries.
Our contract with DLA expires in July 2021 unless the five-year
renewal option is exercised by DLA. Although we expect that DLA
will renew the agreement, there can be no assurance that the
agreement will be renewed. For the years ended December 31,
2020 and 2019, the DLA accounted for 14% of our revenues. The loss
of DLA as a customer could have a material adverse effect on our
financial position and results of operations.
Risks Related to Regulatory and Environmental Matters
The nature of our business exposes us to potential
liability.
The refrigerant recovery and reclamation industry involves
potentially significant risks of statutory and common law liability
for environmental damage and personal injury. We, and in certain
instances, our officers, directors and employees, may be subject to
claims arising from our on-site or off-site services, including the
improper release, spillage, misuse or mishandling of refrigerants
classified as hazardous or non-hazardous substances or materials.
We may be strictly liable for damages, which could be substantial,
regardless of whether we exercised due care and complied with all
relevant laws and regulations. Our current insurance coverage may
not be sufficient to cover potential claims, and adequate levels of
insurance coverage may not be available in the future at a
reasonable cost. A partially or completely uninsured claim against
us, if successful and of sufficient magnitude would have a material
adverse effect on our business and financial condition.
Our business and financial condition is substantially
dependent on the sale and continued environmental regulation of
refrigerants.
Our business and prospects are largely dependent upon continued
regulation of the use and disposition of refrigerants. Changes in
government regulations relating to the emission of refrigerants
into the atmosphere could have a material adverse effect on us.
Failure by government authorities to otherwise continue to enforce
existing regulations or significant relaxation of regulatory
requirements could also adversely affect demand for our services
and products.
Our business is subject to significant regulatory compliance
burdens.
The refrigerant reclamation and management business is subject to
extensive, stringent and frequently changing federal, state and
local laws and substantial regulation under these laws by
governmental agencies, including the EPA, the OSHA and DOT.
Although we believe that we are in material compliance with all
applicable regulations material to our business operations,
amendments to existing statutes and regulations or adoption of new
statutes and regulations that affect the marketing and sale of
refrigerant could require us to continually alter our methods of
operation and/or discontinue the sale of certain of our products
resulting in costs to us that could be substantial. We may not be
able, for financial or other reasons, to comply with applicable
laws, regulations and permit requirements, particularly as we seek
to enter into new geographic markets. Our failure to comply with
applicable laws, rules or regulations or permit requirements
could subject us to civil remedies, including substantial fines,
penalties and injunctions, as well as possible criminal sanctions,
which would, if of significant magnitude, materially adversely
impact our operations and future financial condition.
A number of factors could negatively impact the price and/or
availability of refrigerants, which would, in turn, adversely
affect our business and financial condition.
Refrigerant sales continue to represent a significant majority of
our revenues. Therefore, our business is substantially dependent on
the availability of both new and used refrigerants in large
quantities, which may be affected by several factors including,
without limitation: (i) commercial production and consumption
limitations imposed by the Act and legislative limitations and ban
on HCFC refrigerants; (ii) the amendment to the Montreal
Protocol, if ratified, and any legislation and regulation enacted
to implement the amendment, could impose limitations on production
and consumption of HFC refrigerants; (iii) introduction of new
refrigerants and air conditioning and refrigeration equipment;
(iv) price competition resulting from additional market
entrants; (v) changes in government regulation on the use and
production of refrigerants; and (vi) reduction in price and/or
demand for refrigerants. We do not maintain firm agreements with
any of our suppliers of refrigerants and we do not hold allowances
permitting us to purchase and import HCFC refrigerants from abroad.
Sufficient amounts of new and/or used refrigerants may not be
available to us in the future, particularly as a result of the
further phase down of HCFC production, or may not be available on
commercially reasonable terms. Additionally, we may be subject to
price fluctuations, periodic delays or shortages of new and/or used
refrigerants. Our failure to obtain and resell sufficient
quantities of virgin refrigerants on commercially reasonable terms,
or at all, or to obtain, reclaim and resell sufficient quantities
of used refrigerants would have a material adverse effect on our
operating margins and results of operations.
Issues relating to potential global warming and climate
change could have an impact on our business.
Refrigerants are considered to be strong greenhouse gases that are
believed to contribute to global warming and climate change and are
now subject to various state and federal regulations relating to
the sale, use and emissions of refrigerants. Current and future
global warming and climate change or related legislation and/or
regulations may impose additional compliance burdens on us and on
our customers and suppliers which could potentially result in
increased administrative costs, decreased demand in the marketplace
for our products, and/or increased costs for our supplies and
products. In addition, an amendment to the Montreal Protocol has
established timetables for all developed and developing countries
to freeze and then reduce production and use of HFCs by 85% by
2047, with the first reductions by developed countries in 2019. The
amendment became effective January 1, 2019. In
December 2020, legislation was enacted in the United States
that will require the phasedown of virgin production of HFCs.
Risks Related to Our Common Stock and Other General
Risks
As a result of competition, and the strength of some of our
competitors in the market, we may not be able to compete
effectively.
The markets for our services and products are highly competitive.
We compete with numerous regional and national companies which
provide refrigerant recovery and reclamation services, as well as
companies which market and deal in new and reclaimed alternative
refrigerants, including certain of our suppliers, some of which
possess greater financial, marketing, distribution and other
resources than us. We also compete with numerous manufacturers of
refrigerant recovery and reclamation equipment. Certain of these
competitors have established reputations for success in the service
of air conditioning and refrigeration systems. We may not be able
to compete successfully, particularly as we seek to enter into new
markets.
We have the ability to designate and issue preferred stock,
which may have rights, preferences and privileges greater than
Hudson’s common stock and which could impede a subsequent change in
control of us.
Our Certificate of Incorporation authorizes our Board of Directors
to issue up to 5,000,000 shares of “blank check” preferred stock
and to fix the rights, preferences, privileges and restrictions,
including voting rights, of these shares, without further
shareholder approval. The rights of the holders of our common stock
will be subject to, and may be adversely affected by, the rights of
holders of any additional preferred stock that may be issued by us
in the future. Our ability to issue preferred stock without
shareholder approval could have the effect of making it more
difficult for a third party to acquire a majority of our voting
stock, thereby delaying, deferring or preventing a change in
control of us.
If our common stock were delisted from NASDAQ it could be
subject to “penny stock” rules which would negatively impact
its liquidity and our shareholders’ ability to sell their
shares.
Our common stock is currently listed on the NASDAQ Capital Market.
We must comply with numerous NASDAQ Marketplace rules in order
to continue the listing of our common stock on NASDAQ. There can be
no assurance that we can continue to meet the rules required
to maintain the NASDAQ listing of our common stock. If we are
unable to maintain our listing on NASDAQ, the market liquidity of
our common stock may be severely limited.
Our management has significant control over our
affairs.
Currently, our officers and directors collectively beneficially own
approximately 14% of our outstanding common stock.
Accordingly, our officers and directors are in a position to
significantly affect major corporate transactions and the election
of our directors. There is no provision for cumulative voting for
our directors.
We may fail to successfully integrate any additional
acquisitions made by us into our operations.
As part of our business strategy, we may look for opportunities to
grow by acquiring other product lines, technologies or facilities
that complement or expand our existing business. We may be unable
to identify additional suitable acquisition candidates or negotiate
acceptable terms. In addition, we may not be able to successfully
integrate any assets, liabilities, customers, systems or management
personnel we may acquire into our operations and we may not be able
to realize related revenue synergies and cost savings within
expected time frames. There can be no assurance that we will be
able to successfully integrate any prior or future acquisition.
Our information technology systems, processes, and sites may
suffer interruptions, failures, or attacks which could affect our
ability to conduct business.
Our information technology systems provide critical data
connectivity, information and services for internal and external
users. These include, among other things, processing transactions,
summarizing and reporting results of operations, complying with
regulatory, legal or tax requirements, storing project information
and other processes necessary to manage the business. Our systems
and technologies, or those of third parties on which we rely, could
fail or become unreliable due to equipment failures, software
viruses, cyber threats, terrorist acts, natural disasters, power
failures or other causes. Cybersecurity threats are evolving and
include, but are not limited to, malicious software, cyber
espionage, attempts to gain unauthorized access to our sensitive
information, including that of our customers, suppliers, and
subcontractors, and other electronic security breaches that could
lead to disruptions in mission critical systems, unauthorized
release of confidential or otherwise protected information, and
corruption of data. Although we utilize various procedures and
controls to monitor and mitigate these threats, there can be no
assurance that these procedures and controls will be sufficient to
prevent security threats from materializing. If any of these events
were to materialize, the costs related to cyber or other security
threats or disruptions may not be fully insured or indemnified and
could have a material adverse effect on our reputation, operating
results, and financial condition.
Item 1B. Unresolved Staff
Comments
None.
Item 2. Properties
The Company’s headquarters are located in a multi-tenant building
in Pearl River, New York, which houses the Company’ executive
officers, its accounting and administrative staff, and its
information technology staff and equipment, and the Company also
maintains administrative and sales offices in Long Island City, New
York. The Company’s key reclamation, processing and cylinder
refurbishment facilities are located in Champaign, Illinois
and Smyrna, Georgia. The Company also sells industrial gases out of
facilities located in Escondido, California and in
Champaign, Illinois. The Company maintains smaller reclamation
and cylinder refurbishing facilities in Ontario, California. The
Company also maintains four smaller service depots for the
performance of its RefrigerantSide® Services and maintains three
sales and telemarketing offices.
Hudson’s key operational facilities are as follows:
Location |
|
Owned
or Leased |
|
Description |
Pearl
River, New York |
|
Leased |
|
Company
headquarters and administrative offices |
Champaign, Illinois |
|
Owned |
|
Reclamation
and separation of refrigerants and cylinder
refurbishment |
Champaign, Illinois |
|
Leased |
|
Refrigerant
packaging, cylinder refurbishment, RefrigerantSide® Service depot,
refrigerant and industrial gases storage |
Smyrna,
Georgia |
|
Leased |
|
Reclamation
and separation of refrigerants and cylinder refurbishment
center |
Smyrna,
Georgia |
|
Owned |
|
Refrigerant
storage |
Long
Island City, New York |
|
Leased |
|
Administrative,
sales and marketing offices, refrigerant storage &
shipping |
Escondido, California
Ontario, California
|
|
Leased
Leased
|
|
Refrigerant and Industrial gas storage and cylinder refurbishment
center
Refrigerant reclamation and cylinder refurbishment center
|
Tulsa,
Oklahoma |
|
Leased |
|
Energy
services |
Item 3. Legal
Proceedings
None.
Item 4. Mine Safety
Disclosures
Not Applicable.
Part II
Item 5. Market for Registrant’s
Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities
The Company's common stock trades on the NASDAQ Capital Market
under the symbol “HDSN”.
The number of record holders of the Company's common stock was
approximately 110 as of March 12, 2021. The Company believes
that there are approximately 4,000 beneficial owners of its common
stock.
To date, the Company has not declared or paid any cash dividends on
its common stock. The payment of dividends, if any, in the future
is within the discretion of the Board of Directors and will depend
upon the Company's earnings, its capital requirements and financial
condition, borrowing covenants, and other relevant factors. The
Company presently intends to retain all earnings, if any, to
finance the Company's operations and development of its business
and does not expect to declare or pay any cash dividends on its
common stock in the foreseeable future. In addition, the Company
has a credit facility with Wells Fargo Bank, National Association
and a separate term loan that, among other things, restrict the
Company's ability to declare or pay any cash dividends on its
capital stock.
Item 6. Selected Financial
Data
Not required.
Item 7. Management’s Discussion and
Analysis of Financial Condition and Results of
Operations
Certain statements, contained in this section and elsewhere in this
Form 10-K, constitute “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such forward-looking statements involve a number of known and
unknown risks, uncertainties and other factors which may cause the
actual results, performance or achievements of the Company to be
materially different from any future results, performance or
achievements expressed or implied by such forward-looking
statements. Such factors include, but are not limited to, changes
in the laws and regulations affecting the industry, changes in the
demand and price for refrigerants (including unfavorable market
conditions adversely affecting the demand for, and the price of
refrigerants), the Company's ability to source refrigerants,
regulatory and economic factors, seasonality, competition,
litigation, the nature of supplier or customer arrangements that
become available to the Company in the future, adverse weather
conditions, possible technological obsolescence of existing
products and services, possible reduction in the carrying value of
long-lived assets, estimates of the useful life of its assets,
potential environmental liability, customer concentration, the
ability to obtain financing, the ability to meet financial
covenants under our financing facilities, any delays or
interruptions in bringing products and services to market, the
timely availability of any requisite permits and authorizations
from governmental entities and third parties as well as factors
relating to doing business outside the United States, including
changes in the laws, regulations, policies, and political,
financial and economic conditions, including inflation, interest
and currency exchange rates, of countries in which the Company may
seek to conduct business, and integration of any other assets it
acquires from third parties into its operations, and other risks
detailed in this report and in the Company’s other subsequent
filings with the Securities and Exchange Commission (“SEC”). The
words “believe”, “expect”, “anticipate”, “may”, “plan”, “should”
and similar expressions identify forward-looking statements.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date the
statement was made.
Impact of COVID-19 Pandemic
During the year ended December 31, 2020, the effects of a
novel strain of coronavirus ("COVID-19") pandemic and the related
actions by governments around the world to attempt to contain the
spread of the virus have materially impacted the global
economy.
In response to the COVID-19 outbreak and business disruption, we
have four primary priorities:
• |
To
ensure the health and safety of Hudson employees |
|
|
• |
To
keep our products in supply and to maintain the quality and safety
of our products |
|
|
• |
To
best serve our customers across all channels as they adapt to the
shifting demands of consumers during the crisis |
|
|
• |
To
best position ourselves to emerge strong when this crisis
ends |
We operate in a “critical infrastructure industry” and are an
essential business as defined by the United States government as we
procure, process, service and deliver refrigerants to the
government and wholesale and retail organizations, which also
service both residential homes and commercial institutions
throughout the United States. While the conditions in the United
States and the economy have worsened, we have been effectively
running our operations, including the following:
|
- |
Keeping
all plants open, while maintaining proper safety
standards |
|
- |
Directing
all office personnel to work remotely, efficiently and
safely |
|
- |
Maintaining
ongoing relationships and business with existing customers and
vendors in the supply chain |
As of the date of this filing, we have activated our contingency
plans. We have deployed national and regional teams to monitor the
rapidly evolving situation and recommend risk mitigation actions;
we have implemented travel restrictions; and we are following
social distancing practices. We are endeavoring to follow guidance
from authorities and health officials including, but not limited
to, requiring associates to wear masks and other protective
clothing as appropriate, and implementing additional cleaning and
sanitization routines at system facilities.
During times of crisis, business continuity and adapting to the
needs of our customers is critical. We have developed systemwide
knowledge-sharing routines and processes which include the
management of any supply chain challenges. As of the date of this
filing, there has been no material impact on our ability to procure
or distribute our products and services. We are moving with speed
to best serve our customers impacted by COVID-19 and to ensure
adequate inventory levels in key channels. We have shifted to more
remote and paperless options for customer payments and receipts,
including ACH payments.
Critical Accounting Policies
The Company's discussion and analysis of its financial condition
and results of operations are based upon its consolidated financial
statements, which have been prepared in accordance with accounting
principles generally accepted in the United States. The preparation
of these consolidated financial statements requires the Company to
make estimates and judgments that affect the reported amounts of
assets, liabilities, revenues and expenses and related disclosure
of contingent assets and liabilities. Several of the Company's
accounting policies involve significant judgments, uncertainties
and estimates. The Company bases its estimates on historical
experience and on various other assumptions that are believed to be
reasonable under the circumstances, the results of which form the
basis for making judgments about the carrying values of assets and
liabilities. Actual results may differ from these estimates under
different assumptions or conditions. To the extent that actual
results differ from management's judgments and estimates, there
could be a material adverse effect on the Company. On a continuous
basis, the Company evaluates its estimates, including, but not
limited to, those estimates related to its inventory reserves,
valuation allowance for the deferred tax assets relating to its net
operating loss carry forwards (“NOLs”) and goodwill and intangible
assets.
Inventory
For inventory, the Company evaluates both current and anticipated
sales prices of its products to determine if a write down of
inventory to net realizable value is necessary. Net realizable
value represents the estimated selling price in the ordinary course
of business, less reasonably predictable costs of completion and
disposal. The determination if a write-down to net realizable value
is necessary is primarily affected by the market prices for the
refrigerant gases we sell. Commodity prices generally are affected
by a wide range of factors beyond our control, including weather,
seasonality, the availability and adequacy of supply, government
regulation and policies and general political and economic
conditions. At any time, our inventory levels may be
substantial.
During 2019, the Company recorded a lower of cost or net realizable
value adjustment of $9.2 million to its inventory resulting from a
challenging pricing environment affecting the refrigerant gas
industry. Further declines in refrigerant gas prices could result
in additional inventory net realizable value adjustments. Pricing
has stabilized and increased in 2020 so no such adjustment was
required in 2020.
Goodwill
The Company has made acquisitions that included a significant
amount of goodwill and other intangible assets. The Company applies
the purchase method of accounting for acquisitions, which among
other things, requires the recognition of goodwill (which
represents the excess of the purchase price of the acquisition over
the fair value of the net assets acquired and identified intangible
assets). We test our goodwill for impairment on an annual basis
(the first day of the fourth quarter) and between annual tests if
an event occurs or circumstances change that would more likely than
not reduce the fair value of an asset below its carrying value.
Other intangible assets that meet certain criteria are amortized
over their estimated useful lives.
Beginning in 2017, the Company adopted, on a prospective basis, ASU
No. 2017-04, which simplifies the accounting for goodwill
impairment by eliminating Step 2 of the prior goodwill impairment
test that required a hypothetical purchase price allocation to
measure goodwill impairment. Under the new standard, a company
records an impairment charge based on the excess of a reporting
unit’s carrying amount over its fair value. An impairment charge
would be recognized when the carrying amount exceeds the estimated
fair value of a reporting unit. These impairment evaluations use
many assumptions and estimates in determining an impairment loss,
including certain assumptions and estimates related to future
earnings. If the Company does not achieve its earnings objectives,
the assumptions and estimates underlying these impairment
evaluations could be adversely affected, which could result in an
asset impairment charge that would negatively impact operating
results.
In 2019, due to a significant selling price correction leading to
unfavorable market conditions, the Company performed a quantitative
test by weighing the results of an income-based valuation technique
(the discounted cash flows method) and a market-based valuation
technique to determine the fair value of its reporting unit. The
Company also performed a similar quantitative test for its annual
impairment testing date in 2020.
The discounted cash flow methodology included: (i) management's
estimates, such as discount rates, terminal growth rates, and
projections of revenue, operating margin and cash flows and (ii)
assumptions related to general economic and market conditions,
including inherent uncertainties regarding the projected impact of
the COVID-19 pandemic. The Company initially established a forecast
of the estimated future net cash flows, which were then discounted
to their present value. The market-based valuation technique
utilizes market multiple assumptions for comparable companies to
estimate the fair value of the reporting unit.
There were no goodwill impairment losses recognized in any of the
two years ended December 31, 2020 and 2019.
Other Intangibles
Intangibles with determinable lives are amortized over the
estimated useful lives of the assets currently ranging from 3 to 13
years. The Company reviews these useful lives annually to determine
that they reflect future realizable value.
Income Taxes
The Company is taxed at statutory corporate income tax rates after
adjusting income reported for financial statement purposes for
certain items. Current income tax expense (benefit) reflects the
tax results of revenues and expenses currently taxable or
deductible. The Company utilizes the asset and liability method of
accounting for deferred income taxes, which provides for the
recognition of deferred tax assets or liabilities, based on enacted
tax rates and laws, for the differences between the financial and
income tax reporting bases of assets and liabilities.
The tax benefit associated with the Company’s net operating loss
carry forwards (“NOLs”) is recognized to the extent that the
Company expects to realize future taxable income. As a result of a
prior “change in control”, as defined by the Internal Revenue
Service, the Company’s ability to utilize its existing NOLs is
subject to certain annual limitations. To the extent that the
Company utilizes its NOLs, it will not pay tax on such income.
However, to the extent that the Company’s net income, if any,
exceeds the annual NOL limitation, it will pay income taxes based
on the then existing statutory rates. In addition, certain states
either do not allow or limit NOLs and as such the Company will be
liable for certain state income taxes.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic
Security Act (“CARES Act”) was enacted in response to the COVID-19
pandemic. The CARES Act, among other things, permits NOL carryovers
and carrybacks to offset 100% of taxable income for taxable years
beginning before 2021. In addition, the CARES Act allows NOLs
incurred in 2018, 2019, and 2020 to be carried back to each of the
five preceding taxable years to generate a refund of previously
paid income taxes. The Company has evaluated its options
under the carryback provision and filed a claim for refund,
resulting in a cash benefit. Further, the CARES Act accelerates the
refund of the alternative minimum tax credits to allow a full
refund of any remaining credit amount in taxable years beginning in
2019. The credits were originally fully refundable in taxable years
beginning in 2021. As a result, the Company has recorded a
preliminary $47,000 tax benefit related to the alternative minimum
tax refund in the quarter ended March 31, 2020 and an
additional $380,000 in the quarter ended June 30, 2020.
Finally, the CARES Act contains modifications on the limitation of
business interest for tax years beginning in 2019 and 2020. The
modifications to Section 163(j) increase the allowable
business interest deduction from 30% of adjusted taxable income to
50% of adjusted taxable income. This modification results in a
$2,154,000 increase in allowable interest expense, which in turn
results in an increase to our net operating losses of $2,154,000 in
the year ended December 31, 2020. However, the impact of the
additional interest expense did not impact our income tax provision
since the increase in the deferred tax asset for net operating
losses was offset by an increase to the valuation allowance.
As of December 31, 2020, the Company had NOLs of approximately
$46.1 million, of which $40.7 million have no expiration date and
$5.4 million expire through 2023. As of December 31, 2020, the
Company had state tax NOLs of approximately $31.2 million expiring
in various years. We review the likelihood that we will realize the
benefit of our deferred tax assets, and therefore the need for
valuation allowances, on an annual basis in the fourth quarter of
the year, and more frequently if events indicate that a review is
required. In determining the requirement for a valuation allowance,
the historical and projected financial results are considered,
along with all other available positive and negative evidence.
Concluding
that a valuation allowance is not required is difficult when there
is significant negative evidence that is objective and verifiable,
such as cumulative losses in recent years. We utilize a rolling
twelve quarters of pre-tax income or loss adjusted for significant
permanent book to tax differences, as well as non-recurring items,
as a measure of our cumulative results in recent years. Based on
our assessment as of December 31, 2018 and 2019, we concluded
that due to the uncertainty that the deferred tax assets will not
be fully realized in the future, we recorded a valuation allowance
of approximately $11.3 million during 2018, and due to additional
losses, increased the valuation allowance through 2019 and
December 31, 2020, with an ending balance of $19.0
million as of December 31, 2020.
The Company evaluates uncertain tax positions, if any, by
determining if it is more likely than not to be sustained upon
examination by the taxing authorities. As of December 31, 2020 and
December 31, 2019, the Company believes it had no uncertain
tax positions.
Overview
Sales of refrigerants continue to represent a significant majority
of the Company’s revenues.
In July 2016 the Company was awarded, as prime contractor, a
five-year contract, including a five-year renewal option, by the
United States Defense Logistics Agency (“DLA”) for the management,
supply, and sale of refrigerants, compressed gases, cylinders and
related terms.
Results of Operations
Year ended December 31, 2020 as compared to the year ended
December 31, 2019
Revenues for the year ended December 31, 2020 were $147.6
million, a reduction of $14.5 million or 9% from the $162.1 million
reported during the comparable 2019 period. Most of the variance is
due to a decline in volume. During the 2020 period, the COVID-19
virus pandemic and the associated effect on our economy, including
the closures to public venues, such as office buildings, gyms,
schools and universities across the U.S., negatively impacted our
end markets and overall demand for refrigerants.
Cost of sales for the year ended December 31, 2020 was $112.2
million or 76% of sales. Cost of sales for the year ended
December 31, 2019 was $144.9 million or 89% of sales. In 2020,
the Company has reduced its inventory cost by selling off higher
cost layers of inventory to achieve greater gross profit. During
the three month period ended June 30, 2019, the Company
recorded a lower of cost or net realizable value adjustment to its
inventory of $9.2 million, mainly due to declines in selling prices
of certain refrigerants at that time.
Selling, general and administrative (“SG&A”) expenses for the
year ended December 31, 2020 were $26.6 million, a reduction
of $3.4 million from the $30.0 million reported during the
comparable 2019 period. The decrease in SG&A was due to reduced
professional fees, stock compensation expense, sales commission and
payroll expense.
Amortization expense was $2.9 million during both 2020 and 2019,
respectively.
Other expense for 2020 was $11.3 million, compared to the $9.5
million of other expense reported during the comparable 2019
period. Interest expense was $6.6 million lower in 2020 when
compared to 2019 primarily due to reduced debt resulting from the
Company paying down $14 million of principal of its term loan debt
in December 2019. On June 23, 2020, Kevin J. Zugibe,
Chairman of the Board and Chief Executive Officer of the Company,
passed away unexpectedly; during the third quarter of 2020, the
Company received $1 million of key man life insurance proceeds. In
August 2019, the Company received $8.9 million of cash
pursuant to the settlement of a working capital adjustment dispute
arising from the acquisition of Aspen Refrigerants, Inc. in
October 2017.
Income tax benefit for 2020 was $0.2 million compared to income tax
expense of $0.7 million for 2019. For 2020 and 2019, income tax
expense for federal and state income tax purposes was determined by
applying statutory income tax rates to pre-tax income after
adjusting for certain items. As discussed previously, we concluded
that due to the uncertainty that the deferred tax assets will not
be fully realized in the future, we have recorded a full valuation
allowance as of December 31, 2020.
The net loss for the year ended December 31, 2020 was $5.2 million,
compared to $25.9 million of net loss reported during the
comparable 2019 period. The reduction in net loss is primarily due
to a lower of cost or net realizable value adjustment in 2019,
improved gross margins, reduced SG&A and interest expense,
partially offset by reduced revenue and other income, as described
above.
Liquidity and Capital Resources
At December 31, 2020, the Company had working capital, which
represents current assets less current liabilities, of $24.4
million, a decrease of $3.9 million from the working capital of
$28.3 million at December 31, 2019. The decrease in working
capital is primarily attributable to reduced inventory levels, as
described above, offset by a $12 million paydown of revolving
loans.
Inventory and trade receivables are principal components of current
assets. At December 31, 2020, the Company had inventory of
$44.5 million, a decrease of $14.7 million from $59.2 million at
December 31, 2019. The decrease in the inventory balance is
primarily due to the sale of refrigerants and the timing and
availability of inventory purchases. The Company’s ability to sell
and replace its inventory on a timely basis and the prices at which
it can be sold are subject, among other things, to current market
conditions and the nature of supplier or customer arrangements and
the Company’s ability to source CFC based refrigerants (which are
no longer being produced), HCFC refrigerants (which are currently
being phased down leading to a full phase out of virgin
production), or non-CFC based refrigerants. At December 31,
2020, the Company had trade receivables, net of allowance for
doubtful accounts, of $9.8 million, an increase of $1.7 million
from $8.1 million at December 31, 2019. The Company’s trade
receivables are concentrated with various wholesalers, brokers,
contractors and end-users within the refrigeration industry that
are primarily located in the continental United States. The Company
has historically financed its working capital requirements through
cash flows from operations, the issuance of debt and equity
securities, and bank borrowings.
Net cash provided by operating activities for the year ended
December 31, 2020 was $11.7 million, a reduction of $22.1
million compared to the net cash provided by operating activities
of $33.8 million for the comparable 2019 period. As mentioned
previously, in August 2019, the Company received $8.9 million
of cash pursuant to the settlement of a working capital adjustment
dispute arising from the acquisition of Aspen
Refrigerants, Inc. in October 2017.
Net cash used in investing activities for 2020 and 2019 was $0.5
million and $1.0 million, respectively. As described above, key man
life insurance proceeds of $1.0 million were offset by capital
expenditures incurred in the ordinary course of business, mainly in
our plant facilities.
Net cash used in financing activities for 2020 and 2019 was $12.5
million and $32.5 million, respectively. The Company received a
loan of approximately $2.5 million pursuant to the PPP during the
second quarter of 2020. The Company expects that almost the entire
balance will be forgiven, but the process is not expected to be
finalized until the first half of 2021. As described above, the
Company received an $8.9 million cash settlement of a working
capital adjustment, which it utilized to pay down debt in 2019.
At December 31, 2020, cash and cash equivalents were $1.3
million, or approximately $1.3 million lower than the $2.6 million
of cash and cash equivalents at December 31, 2019. The
variance is mainly due to timing of payments, receipts and
additional paydown of the revolver balance.
Revolving Credit Facility
On December 19, 2019, Hudson Technologies Company (“HTC”),
Hudson Holdings, Inc. (“Holdings”) and Aspen
Refrigerants, Inc. (“ARI”), as borrowers (collectively, the
“Borrowers”), and Hudson Technologies, Inc. (the “Company”) as
a guarantor, became obligated under a Credit Agreement (the “Wells
Fargo Facility”) with Wells Fargo Bank, as administrative agent and
lender (“Agent” or “Wells Fargo”) and such other lenders as may
thereafter become a party to the Wells Fargo Facility.
Under the terms of the Wells Fargo Facility, the Borrowers may
borrow, from time to time, up to $60 million at any time consisting
of revolving loans in a maximum amount up to the lesser of $60
million and a borrowing base that is calculated based on the
outstanding amount of the Borrowers’ eligible receivables and
eligible inventory, as described in the Wells Fargo Facility. The
Wells Fargo Facility also contains a sublimit of $5 million for
swing line loans and $2 million for letters of credit.
Amounts borrowed under the Wells Fargo Facility were used by the
Borrowers to repay existing revolving indebtedness under its prior
revolving credit facility, repay certain principal amounts under
the Term Loan Facility (as defined below), and may be used for
working capital needs, certain permitted acquisitions, and to
reimburse drawings under letters of credit.
Interest on loans under the Wells Fargo Facility is payable in
arrears on the first day of each month. Interest charges with
respect to loans are computed on the actual principal amount of
loans outstanding during the month at a rate per annum equal to
(A) with respect to Base Rate loans, the sum of (i) a
rate per annum equal to the higher of (1) the federal funds
rate plus 0.5%, (2) one month LIBOR plus 1.0%, and
(3) the prime commercial lending rate of Wells Fargo, plus
(ii) between 1.25% and 1.75% depending on average monthly
undrawn availability and (B) with respect to LIBOR rate loans,
the sum of the LIBOR rate plus between 2.25% and 2.75% depending on
average monthly undrawn availability.
In connection with the closing of the Wells Fargo Facility, the
Company also entered into a Guaranty and Security Agreement, dated
as of December 19, 2019 (the “Revolver Guaranty and Security
Agreement”), pursuant to which the Company and certain subsidiaries
unconditionally guaranteed the payment and performance of all
obligations owing by Borrowers to Wells Fargo, as Agent for the
benefit of the revolving lenders. Pursuant to the Revolver Guaranty
and Security Agreement, Borrowers, the Company and ten other
subsidiaries granted to the Agent, for the benefit of the Wells
Fargo Facility lenders, a security interest in substantially all of
their respective assets, including receivables, equipment, general
intangibles (including intellectual property), inventory,
subsidiary stock, real property, and certain other assets. The
Revolver Guaranty and Security Agreement also provides that the
Agent shall receive the right to dominion over certain of the
Borrowers’ bank accounts in the event of an Event of Default under
the Wells Fargo Facility, or if undrawn availability under the
Wells Fargo Facility falls below $9 million at any time.
The Wells Fargo Facility contains a financial covenant requiring
the Company to maintain at all times minimum liquidity (defined as
availability under the Wells Fargo Facility plus unrestricted cash)
of at least $5 million, of which at least $3 million must be
derived from availability. The Wells Fargo Facility also contains a
springing covenant, which takes effect only upon a failure to
maintain undrawn availability of at least $7.5 million, requiring
the Company to maintain a Fixed Charge Coverage Ratio (FCCR) of not
less than 1.00 to 1.00, as of the end of each trailing period of
twelve consecutive fiscal months commencing with the month prior to
the triggering of the covenant. The FCCR (as defined in the Wells
Fargo Facility) is the ratio of (a) EBITDA for such period,
minus unfinanced capital expenditures made during such period, to
(b) the aggregate amount of (i) interest expense required
to be paid (other than interest paid-in-kind, amortization of
financing fees, and other non-cash interest expense) during such
period, (ii) scheduled principal payments (but excluding
principal payments relating to outstanding revolving loans under
the Wells Fargo Facility), (iii) all net federal, state, and
local income taxes required to be paid during such period
(provided, that any tax refunds received shall be applied to the
period in which the cash outlay for such taxes was made),
(iv) all restricted payments paid (as defined in the Wells
Fargo Facility) during such period, and (v) to the extent not
otherwise deducted from EBITDA for such period, all payments
required to be made during such period in respect of any funding
deficiency or funding shortfall with respect to any pension plan.
The FCCR covenant ceases after the Borrowers have been in
compliance therewith for two consecutive months.
The Wells Fargo Facility also contains customary non-financial
covenants relating to the Company and the Borrowers, including
limitations on Borrowers’ ability to pay dividends on common stock
or preferred stock, and also includes certain events of default,
including payment defaults, breaches of representations and
warranties, covenant defaults, cross-defaults to other obligations,
events of bankruptcy and insolvency, certain ERISA events,
judgments in excess of specified amounts, impairments to guarantees
and a change of control. The Wells Fargo Facility also contains
certain covenants contained in the Fourth Amendment to the Term
Loan Facility described below.
On April 23, 2020, the Borrowers, the Company and its
subsidiaries entered into a First Amendment to Credit Agreement
with Wells Fargo (the “First Amendment”). The First Amendment
authorized the Company and its subsidiaries to incur up to $2.5
million of indebtedness under the Coronavirus Aid, Relief, and
Economic Security Act (the “CARES Act”) and contained other
provisions relating to the treatment of such proceeds and any
potential debt forgiveness, under the Wells Fargo Facility.
The commitments under the Wells Fargo Facility will expire and the
full outstanding principal amount of the loans, together with
accrued and unpaid interest, are due and payable in full on
December 19, 2022, unless the commitments are terminated and
the outstanding principal amount of the loans are accelerated
sooner following an event of default.
Term Loan Facility
On October 10, 2017, HTC, Holdings, and ARI, as borrowers, and
the Company, as guarantor, became obligated under a Term Loan
Credit and Security Agreement (as amended, the “Term Loan
Facility”) with U.S. Bank National Association, as administrative
agent and collateral agent (“Term Loan Agent”) and funds
advised by FS Investments and such other lenders as may thereafter
become a party to the Term Loan Facility (the “Term Loan
Lenders”).
Under the terms of the Term Loan Facility, the Borrowers
immediately borrowed $105 million pursuant to a term loan (the
“Term Loan”).
The Term Loan matures on October 10, 2023. Interest on the
Term Loan is generally payable on the earlier of the last day
of the interest period applicable to such Eurodollar rate loan and
the last day of the Term Loan Facility, as applicable. Interest is
payable at the rate per annum of the Eurodollar Rate (as defined in
the Term Loan Facility) plus 10.25%. The Borrowers have the
option of paying 3.00% interest per annum in kind by adding such
amount to the principal of the Term Loans during no more than five
fiscal quarters during the term of the Term Loan Facility.
Borrowers and the Company granted to the Term Loan Agent, for the
benefit of the Term Loan Lenders, a security interest in
substantially all of their respective assets, including
receivables, equipment, general intangibles (including intellectual
property), inventory, subsidiary stock, real property, and certain
other assets.
The Term Loan Facility contains a financial covenant requiring the
Company to maintain a specified total leverage ratio (“TLR”),
tested as of the last day of the fiscal quarter. The TLR (as
defined in the Term Loan Facility) is the ratio of (a) funded
debt as of such day to (b) EBITDA for the four consecutive
fiscal quarters ending on the last day of such fiscal quarter.
Funded debt (as defined in the Term Loan Facility) includes amounts
borrowed under the Wells Fargo Facility and the Term Loan Facility
as well as capitalized lease obligations and other indebtedness for
borrowed money maturing more than one year from the date of
creation thereof. As of December 31, 2020 and 2019, the TLR was
approximately 5.84 to 1 and 11.22 to 1, respectively.
The Term Loan Facility also contains customary non-financial
covenants relating to the Company and the Borrowers, including
limitations on their ability to pay dividends on common stock or
preferred stock, and also includes certain events of default,
including payment defaults, breaches of representations and
warranties, covenant defaults, cross-defaults to other obligations,
events of bankruptcy and insolvency, certain ERISA events,
judgments in excess of specified amounts, impairments to guarantees
and a change of control.
In connection with the closing of the Term Loan Facility, the
Company also entered into a Guaranty and Suretyship Agreement,
dated as of October 10, 2017 (the “Term Loan Guarantee”),
pursuant to which the Company affirmed its unconditional guarantee
of the payment and performance of all obligations owing by
Borrowers to Term Loan Agent, as agent for the benefit of the Term
Loan Lenders.
The Term Loan Agent and the Agent have entered into an
intercreditor agreement governing the relative priority of their
security interests granted by the Borrowers and the Guarantor in
the collateral, providing that the Agent shall have a first
priority security interest in the accounts receivable, inventory,
deposit accounts and certain other assets (the “Revolving Credit
Priority Collateral”) and the Term Loan Agent shall have a first
priority security interest in the equipment, real property, capital
stock of subsidiaries and certain other assets (the “Term Loan
Priority Collateral”).
On December 19, 2019, HTC, Holdings and ARI as borrowers and
the Company as a guarantor, entered into a Waiver and Fourth
Amendment to Term Loan Credit and Security Agreement (the “Fourth
Amendment”) with U.S. Bank National Association, as collateral
agent and administrative agent, and the various lenders
thereunder.
The Fourth Amendment waived financial covenant defaults at
June 30, 2019 and September 30, 2019 and amended the Term
Loan Credit and Security Agreement dated October 10, 2017 (as
previously amended, the “Term Loan Facility”) to reset the maximum
Total Leverage Ratio covenant contained in the Term Loan Facility
at the indicated dates as follows: (i) September 30, 2019
- 15.67:1.00; (ii) December 31, 2019 – 14.54:1.00;
(iii) March 31, 2020 – 16.57:1.00;
(iv) June 30, 2020 – 10.87:1.00;
(v) September 30, 2020 – 8.89:1.00;
(vi) December 31, 2020 – 8.89:1.00;
(vii) March 31, 2021 – 7.75:1.00;
(viii) June 30, 2021 – 7.03:1.00;
(ix) September 30, 2021 – 6.08:1.00; and
(x) December 31, 2021 – 5.36:1.00. The Fourth Amendment
also reset the minimum liquidity requirement (consisting of cash
plus undrawn availability on the Borrowers’ revolving loan
facility) of $5 million, measured monthly. Furthermore, the Fourth
Amendment added a minimum LTM Adjusted EBITDA covenant as of the
indicated dates as follows: (i) September 30, 2019 -
$7.887 million; (ii) December 31, 2019 – $7.954 million;
(iii) March 31, 2020 – $7.359 million;
(iv) June 30, 2020 – $11.745 million;
(v) September 30, 2020 – $12.021 million;
(vi) December 31, 2020 – $12.300 million;
(vii) March 31, 2021 –$14.295 million;
(viii) June 30, 2021 – $14.566 million;
(ix) September 30, 2021 – $15.431 million; and
(x) December 31, 2021 – $16.267 million.
The Fourth Amendment also (i) continues the limitation on
acquisitions and dividends, (ii) required a principal
repayment of $14,000,000 upon execution of the Fourth Amendment and
(iii) increases the scheduled quarterly principal repayments
to $562,000 effective March 31, 2020 and $1,312,000 effective
December 31, 2020.
The Fourth Amendment also terminated the exit fee payable to the
term loan lenders, which would have been payable in full in cash
upon the earlier to occur of (x) repayment in full of the term
loans, or (y) any acceleration of the term loans. In lieu of
the exit fee, the Fourth Amendment reinstated a prepayment premium
equal to the following percentages of the principal amount prepaid,
depending upon the date of prepayment: (i) through
March 31, 2020 – 0.50%; (ii) from April 1, 2020
through March 31, 2021 – 2.50%; and (iii) from
April 1, 2021 and thereafter – 5.00%.
The Fourth Amendment also added a new covenant providing that in
the event of a breach of a financial covenant contained in the Term
Loan Facility or any failure to make a required principal repayment
(a “Trigger Event”), then on or prior to six months after a Trigger
Event, the Company shall commence a process to (x) sell its
businesses and/or assets, and/or (y) consummate a refinancing
transaction with respect to the Term Loan Facility (a
“Transaction”), in each case, subject to enumerated time milestones
contained in the Fourth Amendment, and which requires that
Transaction shall, in any event, be consummated on or prior to the
eighteen (18) month anniversary of the Trigger Event.
As closing conditions to the execution and delivery of the Fourth
Amendment, the Company was required to: (i) amend its Bylaws
in a manner acceptable to the Term Loan Facility lenders;
(ii) appoint two new independent directors to the board of
directors (the “Special Directors”); and (iii) pay an
amendment fee of 0.50% of the amount of the outstanding loans under
the Term Loan Facility.
On April 23, 2020, HTC, Holdings and ARI as borrowers and the
Company as a guarantor, entered into a Fifth Amendment to Term Loan
Credit and Security Agreement (the “Fifth Amendment”) with U.S.
Bank National Association, as collateral agent and administrative
agent, and the various lenders thereunder. The Fifth Amendment
authorized the Company and its subsidiaries to incur up to $2.5
million of indebtedness under the CARES Act and contained other
provisions relating to the treatment of such proceeds and any
potential debt forgiveness, under the Term Loan Facility.
The Company evaluated the Fourth and Fifth Amendments in accordance
with the provisions of Accounting Standards Codification (“ASC”)
470, Debt, to determine if the Amendments were (1) a troubled
debt restructuring, and if not, (2) a modification or an
extinguishment of debt. The Company concluded that the Fourth
Amendment was a troubled debt restructuring for accounting purposes
due to the removal of the exit fee; as such, the Company
capitalized an additional $0.5 million of deferred financing costs,
which are being amortized over the remaining term. The future
undiscounted cash flows of the term loan, as amended, exceeded the
carrying value, and accordingly, no gain was recognized and no
adjustment was made to the carrying value of the debt.
The Company was in compliance with all covenants, under the Wells
Fargo Facility and the Term Loan Facility, as amended, as of
December 31, 2020.
The Company’s ability to comply with these covenants in future
quarters may be affected by events beyond the Company’s control,
including general economic conditions, weather conditions,
regulations and refrigerant pricing. Therefore, we cannot make any
assurance that we will continue to be in compliance during future
periods.
The Company believes that it will be able to satisfy its working
capital requirements for the foreseeable future from anticipated
cash flows from operations and available funds under the Wells
Fargo Facility. Any unanticipated expenses, including, but not
limited to, an increase in the cost of refrigerants purchased by
the Company, an increase in operating expenses or failure to
achieve expected revenues from the Company’s RefrigerantSide®
Services and/or refrigerant sales or additional expansion or
acquisition costs that may arise in the future would adversely
affect the Company’s future capital needs. There can be no
assurance that the Company’s proposed or future plans will be
successful, and as such, the Company may require additional capital
sooner than anticipated, which capital may not be available on
acceptable terms, or at all.
CARES Act Loan
On April 23, 2020 the Company received a loan in the amount of
$2.475 million from Meridian Bank under the Paycheck Protection
Program (“PPP”) pursuant to the CARES Act. The loan has a term of
two years, is unsecured, and bears interest at a fixed rate of one
percent per annum, with the first six months of principal and
interest deferred. As a result of the COVID-19 pandemic, in
applying for the loan the Company made a good faith assertion based
upon the degree of uncertainty introduced to the capital markets
and the industries affecting the Company's customers and the
Company's dependency to curtail expenses to fund ongoing
operations. The PPP loan proceeds have been used in part to
help offset payroll costs as stipulated in the legislation. All or
a portion of the PPP loan may be forgiven by the U.S. Small
Business Administration (“SBA”) upon application by the Company and
upon documentation of expenditures in accordance with the SBA
requirements. Under the CARES Act, loan forgiveness is available
for the sum of documented payroll costs and other covered areas,
such as rent payments, mortgage interest and utilities, as
applicable. The Company has applied for loan forgiveness and
intends to comply with the loan forgiveness provisions in the
legislation, however, there are no assurances that the Company will
obtain full forgiveness of the loan based on current
guidelines.
Inflation
Inflation has not historically had a material impact on the
Company's operations.
Reliance on Suppliers and Customers
The Company participates in an industry that is highly regulated,
and changes in the regulations affecting our business could affect
our operating results. Currently the Company purchases virgin HCFC
and HFC refrigerants and reclaimable, primarily HCFC and CFC,
refrigerants from suppliers and its customers. Under the Act the
phase-down of future production of certain virgin HCFC refrigerants
commenced in 2010 and has been fully phased out by the year 2020,
and production of all virgin HCFC refrigerants is scheduled to be
phased out by the year 2030. To the extent that the Company is
unable to source sufficient quantities of refrigerants or is unable
to obtain refrigerants on commercially reasonable terms or
experiences a decline in demand and/or price for refrigerants sold
by it, the Company could realize reductions in revenue from
refrigerant sales, which could have a material adverse effect on
the Company’s operating results and financial position.
For the year ended December 31, 2020, one customer accounted
for 14% of the Company’s revenues; no other customer accounted for
more than 10% of the Company’s revenues. At December 31, 2020,
there were $2.9 million of outstanding receivables from this
customer. For the year ended December 31, 2019, one customer
accounted for 14% of the Company’s revenues; no other customer
accounted for more than 10% of the Company’s revenues. At
December 31, 2019, there were $1.8 million of outstanding
receivables from this customer.
The loss of a principal customer or a decline in the economic
prospects of and/or a reduction in purchases of the Company's
products or services by any such customer could have a material
adverse effect on the Company's operating results and financial
position.
Seasonality and Weather Conditions and Fluctuations in Operating
Results
The Company's operating results vary from period to period as a
result of weather conditions, requirements of potential customers,
non-recurring refrigerant and service sales, availability and price
of refrigerant products (virgin or reclaimable), changes in
reclamation technology and regulations, timing in introduction
and/or retrofit or replacement of refrigeration equipment, the rate
of expansion of the Company's operations, and by other factors. The
Company's business is seasonal in nature with peak sales of
refrigerants occurring in the first nine months of each year.
During past years, the seasonal decrease in sales of refrigerants
has resulted in losses particularly in the fourth quarter of the
year. In addition, to the extent that there is unseasonably cool
weather throughout the spring and summer months, which would
adversely affect the demand for refrigerants, there would be a
corresponding negative impact on the Company. Delays or inability
in securing adequate supplies of refrigerants at peak demand
periods, lack of refrigerant demand, increased expenses, declining
refrigerant prices and a loss of a principal customer could result
in significant losses. There can be no assurance that the foregoing
factors will not occur and result in a material adverse effect on
the Company's financial position and significant losses. The
Company believes that to a lesser extent there is a similar
seasonal element to RefrigerantSide® Service revenues as
refrigerant sales.
Off-Balance Sheet Arrangements
None.
Recent Accounting Pronouncements
In June 2016, the FASB issued ASU
No. 2016-13, Measurement of Credit Losses on Financial
Instruments, which revises guidance for the accounting for credit
losses on financial instruments within its scope, and in
November 2018, issued ASU No. 2018-19 and in
April 2019, issued ASU No. 2019-04 and in May 2019,
issued ASU No. 2019-05, and in November 2019, issued ASU
No. 2019-11, which each amended the standard. The new standard
introduces an approach, based on expected losses, to estimate
credit losses on certain types of financial instruments and
modifies the impairment model for available-for-sale debt
securities. The new approach to estimating credit losses (referred
to as the current expected credit losses model) applies to most
financial assets measured at amortized cost and certain other
instruments, including trade and other receivables, loans,
held-to-maturity debt securities, net investments in leases and
off-balance-sheet credit exposures. This ASU is effective for
fiscal years beginning after December 15, 2022, including
interim periods within those fiscal years, with early adoption
permitted. Entities are required to apply the standard’s provisions
as a cumulative-effect adjustment to retained earnings as of the
beginning of the first reporting period in which the guidance is
adopted. The Company is still evaluating the impact of this
ASU.
In March 2020, the FASB issued ASU 2020-04, which provides
relief from accounting analysis and impacts that may otherwise be
required for modifications to agreements necessitated by reference
rate reform. It also provides optional expedients to enable the
continuance of hedge accounting where certain hedging relationships
are impacted by reference rate reform. This optional guidance is
effective immediately, and available to be used through
December 31, 2022. We are assessing the impact that reference
rate reform and the related adoption of this guidance will have on
our financial statements.
In August 2020, the FASB issued ASU 2020-06, "Debt-Debt with
Conversion and Other Options (Subtopic 470-20) and Derivatives and
Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity's
Own Equity", which is intended to simplify the accounting for
convertible instruments by removing certain separation models in
Subtopic 470-20, Debt-Debt with Conversion and Other Options, for
convertible instruments. The pronouncement is effective for fiscal
years, and for interim periods within those fiscal years, beginning
after December 15, 2021, with early adoption permitted. We are
currently in the process of evaluating the effects of the
provisions of ASU 2020-06 on our financial statements.
Item 7A. Quantitative and
Qualitative Disclosures about Market Risk
Interest Rate Sensitivity
We are exposed to market risk from fluctuations in interest rates
on the Wells Fargo Facility and on the Term Loan Facility. The
Wells Fargo Facility is a $60,000,000 secured facility, and the
Term Loan Facility provides for Term Loans of $85,114,500 as of
December 31, 2020.
There was a $2,000,000 outstanding balance on the Wells Fargo
Facility as of December 31, 2020. Future interest rate changes
on our borrowing under the Wells Fargo Facility may have an impact
on our consolidated results of operations.
There was an $85,114,500 outstanding balance on the Term Loan
Facility as of December 31, 2020. Future interest rate changes
on our borrowing under the Term Loans may have an impact on our
consolidated results of operations.
If the loan bearing interest rate changed by 1%, the annual effect
on interest expense would be approximately $0.9 million as of
December 31, 2020.
Refrigerant Market
We are also exposed to market risk from fluctuations in the demand,
price and availability of refrigerants. To the extent that the
Company is unable to source sufficient quantities of refrigerants
or is unable to obtain refrigerants on commercially reasonable
terms, or experiences a decline in demand and/or price for
refrigerants sold by the Company, the Company could realize
reductions in revenue from refrigerant sales or write downs of
inventory, which could have a material adverse effect on our
consolidated results of operations.
Item 8. Financial
Statements and Supplementary Data
The financial statements appear in a separate section of this
report following Part IV.
Item 9. Changes in and
Disagreements with Accountants on Accounting and Financial
Disclosure
Not Applicable.
Item 9A. Controls and
Procedures
Disclosure Controls and Procedures
The Company, under the supervision and with the participation of
the Company’s management, including the Company’s Chief Executive
Officer and Chief Financial Officer, has evaluated the
effectiveness of the Company’s disclosure controls and procedures,
as defined in Rule 13a-15(e) of the Securities Exchange
Act of 1934, as amended (“Exchange Act”), as of the end of the
period covered by this report. Based on that evaluation, the Chief
Executive Officer and the Chief Financial Officer have concluded
that the Company’s disclosure controls and procedures were
effective and provided reasonable assurance that information
required to be disclosed in reports filed under the Exchange Act is
recorded, processed, summarized and reported within the time
periods specified in the rules and forms of the Securities and
Exchange Commission, and that such information is accumulated and
communicated to the Company’s management, including its principal
executive officer and principal financial officer, as appropriate,
to allow timely decisions regarding required disclosure. Because of
the inherent limitations in all control systems, any controls and
procedures, no matter how well designed and operated, can provide
only reasonable assurance of achieving the desired control
objectives, and management necessarily is required to apply its
judgment in evaluating the cost-benefit relationship of possible
controls and procedures. Furthermore, the Company’s controls and
procedures can be circumvented by the individual acts of some
persons, by collusion of two or more people or by management
override of the control and misstatements due to error or fraud may
occur and not be detected on a timely basis.
Changes in Internal Control over Financial Reporting
As required by Rule 13a-15(d) of the Exchange Act, our
management, including our principal executive officer and our
principal financial officer, conducted an evaluation of the
internal control over financial reporting to determine whether any
changes occurred during the quarter ended December 31, 2020
that have materially affected, or are reasonably likely to
materially affect, our internal control over financial reporting.
Based on that evaluation, our principal executive officer and
principal financial officer concluded there were no such
changes.
Management’s Report on Internal Control over Financial
Reporting
Management of the Company is responsible for establishing and
maintaining adequate internal control over financial reporting for
the Company as defined in Rule 13a-15(f) under the
Exchange Act. The Company’s internal control over financial
reporting is designed to provide reasonable assurance to the
Company’s management and board of directors regarding the
preparation and fair presentation of published financial statements
and the reliability of financial reporting.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Therefore, even those systems determined to be effective can
provide only reasonable assurance with respect to financial
statement preparation and presentation.
The Company’s Chief Executive Officer and Chief Financial Officer
have assessed the effectiveness of the Company’s internal control
over financial reporting as of December 31, 2020. In making
this assessment, the Company’s Chief Executive Officer and Chief
Financial Officer have used the criteria set forth by the Committee
of Sponsoring Organizations of the Treadway Commission (“COSO”) in
Internal Control – Integrated Framework (2013). Based on our
assessment, the Company’s Chief Executive Officer and Chief
Financial Officer believe that, as of December 31, 2020, the
Company’s internal control over financial reporting is effective
based on those criteria.
Due to our filing status as a non-accelerated filer, BDO USA, LLP,
the independent registered public accounting firm which audits our
financial statements, was not required to provide an attestation
report on our internal control over financial reporting as of
December 31, 2020.
Item 9B. Other
Information
None.
Part III
Item 10. Directors, Executive Officers and Corporate
Governance
Reference is made to the disclosure required by Items 401, 405,
406, and 407(c)(3), (d)(4), and (d)(5) of Regulation S-K to be
contained in the Registrant's definitive proxy statement to be
mailed to stockholders on or about April 28, 2021, and to be
filed with the Securities and Exchange Commission.
Item 11. Executive
Compensation
Reference is made to the disclosure required by Items 402 and
407(e)(4) and (e)(5) of Regulation S-K to be contained in
the Registrant's definitive proxy statement to be mailed to
stockholders on or about April 28, 2021, and to be filed with
the Securities and Exchange Commission.
Item 12. Security Ownership
of Certain Beneficial Owners and Management and Related Stockholder
Matters
Reference is made to the disclosure required by Item 403 of
Regulation S-K to be contained in the Registrant's definitive proxy
statement to be mailed to stockholders on or about April 28,
2021, and to be filed with the Securities Exchange Commission.
Equity Compensation Plans
The following table provides certain information with respect to
all of Hudson’s equity compensation plans as of December 31,
2020.
|
|
Number of
securities to be
issued upon
exercise of
outstanding
options |
|
|
Weighted-average
exercise
price of outstanding
options |
|
|
Number of
securities
remaining
available for
future issuance
under equity
compensation
plans
(excluding
securities
reflected
in column (a)) |
|
Plan Category |
|
(a) |
|
|
(b) |
|
|
(c) |
|
Equity compensation plans approved by security holders |
|
|
5,329,515 |
|
|
$ |
1.06 |
|
|
|
4,070,936 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 13. Certain
Relationships and Related Transactions, and Director
Independence
Reference is made to the disclosure required by Items 404 and
407(a) of Regulation S-K to be contained in the Registrant's
definitive proxy statement to be mailed to stockholders on or about
April 28, 2021, and to be filed with the Securities and
Exchange Commission.
Item 14. Principal
Accountant Fees and Services
Reference is made to the proposal regarding the approval of the
Registrant's independent registered public accounting firm to be
contained in the Registrant's definitive proxy statement to be
mailed to stockholders on or about April 28, 2021, and to be
filed with the Securities and Exchange Commission.
Part IV
Item 15. |
|
Exhibits and Financial Statement
Schedules |
(A)(1) |
|
Financial Statements |
|
|
The consolidated financial statements
of Hudson Technologies, Inc. appear after Item 16 of this
report |
(A)(2) |
|
Financial Statement
Schedules |
|
|
None |
(A)(3) |
|
Exhibits |
2.1 |
|
Stock Purchase Agreement, dated
August 9, 2017, by and among Hudson Technologies, Inc., Hudson
Holdings, Inc. and Airgas, Inc. (17) |
3.1 |
|
Certificate of Incorporation and
Amendment. (1) |
3.2 |
|
Amendment to Certificate of
Incorporation, dated July 20, 1994. (1) |
3.3 |
|
Amendment to Certificate of
Incorporation, dated October 26, 1994. (1) |
3.4 |
|
Certificate of Amendment of the Certificate of
Incorporation dated March 16, 1999. (2) |
3.5 |
|
Certificate of Correction of the Certificate of
Amendment dated March 25, 1999. (2) |
3.6 |
|
Certificate of Amendment of the Certificate of
Incorporation dated March 29, 1999. (2) |
3.7 |
|
Certificate of Amendment of the
Certificate of Incorporation dated February 16,
2001. (3) |
3.8 |
|
Certificate of Amendment of the
Certificate of Incorporation dated March 20,
2002. (4) |
3.9 |
|
Amendment to Certificate of
Incorporation dated January 3, 2003. (5) |
3.10 |
|
Amended and Restated By-Laws adopted
December 18, 2019. (28) |
3.11 |
|
Certificate of Amendment of the
Certificate of Incorporation dated September 15,
2015. (14) |
4.1 |
|
Description of Equity Securities.
(33) |
10.1 |
|
2004 Stock Incentive Plan.
(7)* |
10.2 |
|
Amended and Restated Employment
Agreement with Kevin J. Zugibe, as amended. (9)* |
10.3 |
|
Agreement with Brian F. Coleman, as
amended. (9)* |
10.4 |
|
2008 Stock Incentive Plan.
(8)* |
10.5 |
|
Form of Incentive Stock Option
Agreement under the 2008 Stock Incentive Plan with full vesting
upon issuance. (9)* |
10.6 |
|
Form of Incentive Stock Option
Agreement under the 2008 Stock Incentive Plan with options vesting
in equal installments over two year period. (9)* |
10.7 |
|
Form of Non-Incentive Stock Option
Agreement under the 2008 Stock Incentive Plan with full vesting
upon issuance. (9)* |
10.8 |
|
Form of Non-Incentive Stock Option
Agreement under the 2008 Stock Incentive Plan with options vesting
in equal installments over two year period. (9)* |
10.9 |
|
First Amendment to Amended and
Restated Employment Agreement with Kevin J. Zugibe, dated December
30, 2008. (9)* |
10.10 |
|
Long Term Care Insurance Plan
Summary. (10)* |
10.11 |
|
Amendment
No. 1 to the Hudson Technologies, Inc. 2008 Stock Incentive Plan
adopted October 22, 2013. (11) * |
10.12 |
|
2014
Stock Incentive Plan (12)* |
10.13 |
|
Form
of Incentive Stock Option Agreement under the 2014 Stock Incentive
Plan with full vesting upon issuance. (13)* |
10.14 |
|
Form
of Incentive Stock Option Agreement under the 2014 Stock Incentive
Plan with options vesting in equal installments over two year
period. (13)* |
10.15 |
|
Form
of Non-Incentive Stock Option Agreement under the 2014 Stock
Incentive Plan with full vesting upon issuance.
(13)* |
10.16 |
|
Form
of Non-Incentive Stock Option Agreement under the 2014 Stock
Incentive Plan with options vesting in equal installments over two
year period. (13)* |
10.17 |
|
Form
of Incentive Barrier Stock Option Agreement under the 2014 Stock
Incentive Plan with full vesting upon issuance.
(13)* |
10.18 |
|
Form
of Non-Incentive Barrier Stock Option Agreement under the 2014
Stock Incentive Plan with full vesting upon issuance.
(13)* |
10.19 |
|
Form
of Incentive Barrier Stock Option Agreement under the 2008 Stock
Incentive Plan with full vesting upon issuance.
(13)* |
10.20 |
|
Form
of Non-Incentive Barrier Stock Option Agreement under the 2008
Stock Incentive Plan with full vesting upon issuance.
(13)* |
10.21 |
|
Second
Amended and Restated Employment Agreement with Kevin J. Zugibe.
(15)* |
10.22 |
|
Amended
and Restated Agreement with Brian Coleman (15)* |
10.23 |
|
Agreement,
dated September 5, 2016, between Hudson Technologies, Inc. and Nat
Krishnamurti. (16)* |
10.24 |
|
Term
Loan Credit and Security Agreement dated October 10, 2017 with U.S.
Bank National Association as Administrative Agent and Collateral
Agent for the Term Lenders (18) |
10.25 |
|
Guaranty
and Suretyship Agreement dated October 10, 2017 by Hudson
Technologies, Inc. (18) |
10.26 |
|
2018
Stock Incentive Plan (19)* |
10.27 |
|
Form
of Incentive Stock Option Agreement under the 2018 Stock Incentive
Plan with full vesting upon issuance (25)* |
10.28 |
|
Form
of Incentive Stock Option Agreement under the 2018 Stock Incentive
Plan with vesting in equal installments over a specified of time.
(25)* |
10.29 |
|
Form
of Non-Qualified Stock Option Agreement under the 2018 Stock
Incentive Plan with full vesting upon issuances
(25)* |
10.30 |
|
Form
of Non-Qualified Stock Option Agreement under the 2018 Stock
Incentive Plan with vesting in equal installments over a specified
period of time. (25)* |
10.31 |
|
Form
of Non-Qualified Stock Option Agreement under the 2018 Stock
Incentive Plan with conditional vesting provisions.
(25)* |
10.32 |
|
Waiver
and Second Amendment to Term Loan Credit and Security Agreement
(20) |
10.33 |
|
Extension
Letter dated October 15, 2018 (21) |
10.34 |
|
Second
Extension Letter dated November 14, 2018 (22) |
10.35 |
|
Third
Extension Letter dated November 21, 2018 (23) |
10.36 |
|
Waiver
and Third Amendment to Term Loan and Security Agreement
(24) |
10.37 |
|
Joinder
to Term Loan Credit and Security Agreement and Other Documents
(26) |
10.38 |
|
Third
Amended and Restated Employment Agreement dated as of September 20,
2019 between the Registrant and Kevin J. Zugibe
(27)* |
10.39 |
|
Second
Amended and Restated Agreement dated as of September 20, 2019
between the Registrant and Brian F. Coleman (27)* |
10.40 |
|
Amended
and Restated Agreement dated as of September 20, 2019 between the
Registrant and Nat Krishnamurti (27)* |
10.41 |
|
Credit
Agreement dated December 19, 2019 by and among Wells Fargo Bank,
National Association, as Agent, the Lenders that are parties
thereto, Hudson Technologies, Inc. and the Borrowers Described
Therein (28) |
10.42 |
|
Guaranty
and Security Agreement dated December 19, 2019 by and among the
Grantors named therein and Wells Fargo Bank, National Association,
as Agent (28) |
10.43 |
|
Waiver
and Fourth Amendment to Term Loan and Credit and Security Agreement
dated December 19, 2019 (28) |
10.44 |
|
Fourth
Amended and Restated Employment Agreement dated December 19, 2019
between the Registrant and Kevin J. Zugibe (28)* |
10.45 |
|
Third
Amended and Restated Agreement dated December 19, 2019 between the
Registrant and Brian F. Coleman (28)* |
10.46 |
|
First
Amendment to Credit Agreement dated April 23, 2020 with Wells Fargo
Bank, National Association (29) |
10.47 |
|
Fifth
Amendment to Term Loan and Credit and Security Agreement dated
April 23, 2020 (29) |
10.48 |
|
Fourth
Amended and Restated Agreement dated as of June 24, 2020 between
the Registrant and Brian F. Coleman (30)* |
10.49 |
|
Agreement
dated September 14, 2020 between the Company and Kenneth Gaglione
(31)* |
10.50 |
|
Amended
and Restated Agreement dated September 30, 2019 between the Company
and Kathleen L. Houghton (31)* |
10.51 |
|
Hudson
Technologies, Inc. 2020 Stock Incentive Plan (32)* |
10.52 |
|
Form of Incentive Stock Option Agreement under the 2020 Stock
Incentive Plan with full vesting upon issuance
(34)* |
10.53 |
|
Form of Incentive Stock Option Agreement under the 2020 Stock
Incentive Plan with vesting in equal installments over a specified
period of time (34)* |
10.54 |
|
Form of Non-Qualified Stock Option Agreement under the 2020 Stock
Incentive Plan with full vesting upon issuance
(34)* |
10.55 |
|
Form of Non-Qualified Stock Option Agreement under the 2020 Stock
Incentive Plan with vesting in equal installments over a specified
period of time (34)* |
10.56 |
|
Form of Non-Qualified Stock Option Agreement under the 2020 Stock
Incentive Plan with conditional vesting provisions
(34)* |
14 |
|
Code
of Business Conduct and Ethics. (6) |
21 |
|
Subsidiaries
of the Company. (34) |
23.1 |
|
Consent
of BDO USA, LLP. (34) |
31.1 |
|
Certification
of Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002. (34) |
31.2 |
|
Certification
of Chief Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002. (34) |
32.1 |
|
Certification
of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002.
(34) |
32.2 |
|
Certification
of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002.
(34) |
101 |
|
Interactive data file pursuant to Rule 405 of Regulation
S-T. (34) |
(1) |
|
Incorporated by reference to the comparable exhibit filed with the
Company's Registration Statement on Form SB-2 (No.
33-80279-NY). |
(2) |
|
Incorporated by reference to the comparable exhibit filed with the
Company's Quarterly Report on Form 10-QSB for the quarter ended
June 30, 1999. |
(3) |
|
Incorporated by reference to the comparable exhibit filed with the
Company's Annual Report on Form 10-KSB for the year ended December
31, 2000. |
(4) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Annual Report on Form 10-KSB for the year ended December 31,
2001. |
(5) |
|
Incorporated
by reference to the comparable exhibit filed with the Company's
Annual Report on Form 10-KSB for the year ended December 31,
2002. |
(6) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K, for the event dated March 3, 2005, and
filed May 31, 2005. |
(7) |
|
Incorporated
by reference to Appendix B to the Company’s Definitive Proxy
Statement on Schedule 14A filed August 18, 2004 .
|
(8) |
|
Incorporated
by reference to Appendix I to the Company’s Definitive Proxy
Statement on Schedule 14A filed July 29, 2008. |
(9) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Annual Report on Form 10-K for the year ended December 31,
2008. |
(10) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Quarterly Report on Form 10-Q for the quarter ended September 30,
2012. |
(11) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Annual Report on Form 10-K for the year ended December 31,
2013. |
(12) |
|
Incorporated
by reference to Appendix B to the Company’s Definitive Proxy
Statement on Schedule 14A filed August 12,
2014. |
(13) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Quarterly Report on Form 10-Q for the quarter ended September 30,
2014. |
(14) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Quarterly Report on Form 10-Q for the quarter ended September 30,
2015. |
(15) |
|
Incorporated
by reference to the comparable exhibit filed with the Company
Annual Report on form 10-K for the year ended December 31,
2015. |
(16) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed September 9, 2016. |
(17) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed August 9, 2017. |
(18) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed October 11, 2017. |
(19) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Registration Statement on Form S-8 filed December 21,
2018. |
(20) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed August 15, 2018. |
(21) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed October 16, 2018. |
(22) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed November 15, 2018. |
(23) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed November 23, 2018. |
(24) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed December 3, 2018. |
(25) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Annual Report on Form 10-K for the year ended December 31,
2018. |
(26) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Quarterly Report on Form 10-Q for the quarter ended March 31,
2019. |
(27) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed September 23, 2019. |
(28) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed December 20, 2019. |
(29) |
|
Incorporated by reference to the
comparable exhibit filed with the Company’s Quarterly Report on
Form 10-Q filed May 15, 2020.
|
(30) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed July 20, 2020. |
(31) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Current Report on Form 8-K filed September 16, 2020. |
(32) |
|
Incorporated
by reference to the comparable exhibit filed with the Company’s
Registration Statement on Form S-8 filed June 30, 2020. |
(33) |
|
Incorporated by reference to the
comparable exhibit filed with the Company’s Annual Report on Form
10-K filed March 13, 2020. |
(34) |
|
Filed herewith. |
(*) |
|
Denotes
Management Compensation Plan, agreement or arrangement. |
Item 16. Form 10-K
Summary
None.
Hudson Technologies, Inc.
Consolidated Financial Statements
Report of Independent Registered
Public Accounting Firm
Shareholders and Board of Directors
Hudson Technologies, Inc.
Pearl River, NY
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of
Hudson Technologies, Inc. (the “Company”) as of December 31, 2020
and 2019, the related consolidated statements of operations,
stockholders’ equity, and cash flows for each of the two years in
the period ended December 31, 2020, and the related notes
(collectively referred to as the “consolidated financial
statements”). In our opinion, the consolidated financial statements
present fairly, in all material respects, the financial position of
the Company at December 31, 2020 and 2019, and the results of its
operations and its cash flows for each of the two years in the
period ended December 31, 2020, in conformity with
accounting principles generally accepted in the United States of
America.
Basis for Opinion
These consolidated financial statements are the responsibility of
the Company’s management. Our responsibility is to express an
opinion on the Company’s consolidated financial statements based on
our audits. We are a public accounting firm registered with the
Public Company Accounting Oversight Board (United States) (“PCAOB”)
and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and
the PCAOB.
We conducted our audits in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement, whether due
to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of its internal control over financial
reporting. As part of our audits we are required to obtain an
understanding of internal control over financial reporting but not
for the purpose of expressing an opinion on the effectiveness of
the Company’s internal control over financial reporting.
Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of
material misstatement of the consolidated financial statements,
whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a
test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audits also included
evaluating the accounting principles used and significant estimates
made by management, as well as evaluating the overall presentation
of the consolidated financial statements. We believe that our
audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising
from the current period audit of the consolidated financial
statements that was communicated or required to be communicated to
the audit committee and that: (1) relates to accounts or
disclosures that are material to the consolidated financial
statements and (2) involved our especially challenging, subjective,
or complex judgments. The communication of critical audit matter
does not alter in any way our opinion on the consolidated financial
statements, taken as a whole, and we are not, by communicating the
critical audit matter below, providing separate opinions on the
critical audit matter or on the accounts or disclosures to which it
relates.
Goodwill Impairment Assessment
As described in Note 1 and 8 to the Company’s consolidated
financial statements, the Company’s goodwill balance as of December
31, 2020 was $47.8 million. Goodwill is tested for impairment at
the reporting unit level. The Company has one reporting unit at
December 31, 2020. Goodwill is tested for impairment annually on
the first day of the fourth quarter or more frequently if an event
occurs or circumstances change that would make it more likely than
not that the fair value of the reporting unit is less than its
carrying amount. The Company utilizes a weighted combination of the
income approach and the market approach to determine the fair value
of its reporting unit. Significant management estimates and
assumptions are required to evaluate the comparable publicly traded
companies used to derive the market multiples and the forecasts of
future revenue, operating margins and discount rates. Additional
uncertainty existed in the forecasts due to the COVID-19 pandemic
impact on the economic environment.
We identified the determination of the fair value of the reporting
unit as it relates to goodwill impairment assessment as a critical
audit matter. Under the market approach, the reporting unit’s fair
value was estimated using market multiple assumptions for
comparable companies. Under the income approach, a discounted cash
flow methodology was used that included: (i) management’s
estimates, such as discount rates, terminal growth rates, and
projections of revenue, operating margin and cash flows and (ii)
assumptions related to general economic and market conditions,
including inherent uncertainties regarding the projected impact of
the COVID-19 pandemic. These estimates and assumptions require
significant management judgment due to their highly subjective
nature. Changes in these assumptions could have a significant
impact on the fair value of the reporting unit and the amount of
goodwill impairment (if any). Auditing these elements involved
especially challenging auditor judgment in evaluating the
reasonableness of management’s assumptions, including the extent of
specialized skill or knowledge needed.
The primary procedures we performed to address this critical audit
matter included:
|
· |
Evaluating the
appropriateness of the methodologies and reasonableness of
assumptions used by management in determining the fair value of the
reporting unit, including: |
|
o |
With respect to the market
approach, assessing the appropriateness of the approach and
evaluating the reasonableness of the comparable companies and
market multiples selected for the reporting unit. |
|
o |
With respect to the income approach, evaluating
the appropriateness of the approach and the methodology and the
reasonableness of assumptions used through: (i) assessing actual
results against management’s historical forecasts, underlying
business strategies and management’s growth plans and (ii)
evaluating reasonableness of forecasts with evidence obtained in
other areas of the audit, including projected impact of the
COVID-19 pandemic on the industry and the forecasted recovery
period for the industry. |
|
· |
Utilizing personnel with
specialized knowledge and skill of valuation techniques to assist
in: (i) evaluating the appropriateness of the methodologies and the
valuation models utilized by management to determine the fair
values of the reporting unit, and (ii) assessing the reasonableness
of certain assumptions incorporated into the valuation models
including terminal growth rates and discount rates. |
We have served as the Company's auditor since 1994.
Stamford, CT
March 12, 2021
Hudson Technologies, Inc. and Subsidiaries
Consolidated Balance Sheets
(Amounts in thousands, except for share and par value amounts)
|
|
December 31, |
|
|
|
2020 |
|
|
2019 |
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,348 |
|
|
$ |
2,600 |
|
Trade accounts receivable – net |
|
|
9,806 |
|
|
|
8,061 |
|
Inventories |
|
|
44,460 |
|
|
|
59,238 |
|
Prepaid expenses and other current assets |
|
|
6,528 |
|
|
|
4,525 |
|
Total current assets |
|
|
62,142 |
|
|
|
74,424 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, less accumulated depreciation |
|
|
21,910 |
|
|
|
23,674 |
|
Goodwill |
|
|
47,803 |
|
|
|
47,803 |
|
Intangible assets, less accumulated amortization |
|
|
23,150 |
|
|
|
26,012 |
|
Right
of use asset |
|
|
6,559 |
|
|
|
8,048 |
|
Other assets |
|
|
85 |
|
|
|
192 |
|
Total Assets |
|
$ |
161,649 |
|
|
$ |
180,153 |
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Trade accounts payable |
|
$ |
7,644 |
|
|
$ |
10,274 |
|
Accrued expenses and other current liabilities |
|
|
19,417 |
|
|
|
18,120 |
|
Accrued payroll |
|
|
1,394 |
|
|
|
724 |
|
Current maturities of long-term debt |
|
|
7,314 |
|
|
|
3,008 |
|
Short-term debt |
|
|
2,000 |
|
|
|
14,000 |
|
Total current liabilities |
|
|
37,769 |
|
|
|
46,126 |
|
Deferred tax liability |
|
|
1,355 |
|
|
|
1,192 |
|
Long-term lease liabilities |
|
|
3,927 |
|
|
|
5,742 |
|
Long-term debt, less current maturities, net of deferred financing
costs |
|
|
77,976 |
|
|
|
81,982 |
|
Total Liabilities |
|
|
121,027 |
|
|
|
135,042 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Preferred stock, shares authorized 5,000,000: Series A
Convertible preferred stock, $0.01 par value ($100 liquidation
preference value); shares authorized 150,000; none issued or
outstanding |
|
|
— |
|
|
|
— |
|
Common stock, $0.01 par value; shares authorized 100,000,000;
issued and outstanding: 43,347,887 and 42,628,560,
respectively |
|
|
433 |
|
|
|
426 |
|
Additional paid-in capital |
|
|
118,269 |
|
|
|
117,557 |
|
Accumulated deficit |
|
|
(78,080 |
) |
|
|
(72,872 |
) |
Total Stockholders' Equity |
|
|
40,622 |
|
|
|
45,111 |
|
|
|
|
|
|
|
|
|
|
Total Liabilities and Stockholders' Equity |
|
$ |
161,649 |
|
|
$ |
180,153 |
|
See Accompanying Notes to the Consolidated Financial
Statements.
Hudson Technologies, Inc. and Subsidiaries
Consolidated Statements of
Operations
(Amounts in thousands, except for share and per share amounts)
|
|
For the years ended December
31, |
|
|
|
2020 |
|
|
2019 |
|
Revenues |
|
$ |
147,605 |
|
|
$ |
162,059 |
|
Cost of sales |
|
|
112,195 |
|
|
|
144,894 |
|
Gross profit |
|
|
35,410 |
|
|
|
17,165 |
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
26,644 |
|
|
|
30,018 |
|
Amortization |
|
|
2,862 |
|
|
|
2,931 |
|
Total operating expenses |
|
|
29,506 |
|
|
|
32,949 |
|
|
|
|
|
|
|
|
|
|
Operating income (loss) |
|
|
5,904 |
|
|
|
(15,784 |
) |
|
|
|
|
|
|
|
|
|
Other expense: |
|
|
|
|
|
|
|
|
Interest expense |
|
|
(12,330 |
) |
|
|
(18,911 |
) |
Other income |
|
|
1,033 |
|
|
|
9,411 |
|
Total other expense |
|
|
(11,297 |
) |
|
|
(9,500 |
) |
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(5,393 |
) |
|
|
(25,284 |
) |
|
|
|
|
|
|
|
|
|
Income tax (benefit) expense |
|
|
(185 |
) |
|
|
656 |
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(5,208 |
) |
|
$ |
(25,940 |
) |
|
|
|
|
|
|
|
|
|
Net loss per common share – Basic |
|
$ |
(0.12 |
) |
|
$ |
(0.61 |
) |
Net loss per common share – Diluted |
|
$ |
(0.12 |
) |
|
$ |
(0.61 |
) |
|
|
|
|
|
|
|
|
|
Weighted average number of shares outstanding – Basic |
|
|
42,710,381 |
|
|
|
42,613,478 |
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares outstanding – Diluted |
|
|
42,710,381 |
|
|
|
42,613,478 |
|
See Accompanying Notes to the Consolidated Financial
Statements.
Hudson Technologies, Inc. and Subsidiaries
Consolidated Statements of
Stockholders' Equity
(Amounts in thousands, except for share amounts)
|
|
|
|
|
|
|
|
Retained |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings |
|
|
|
|
|
|
Common Stock |
|
|
Additional |
|
|
(Accumulated |
|
|
|
|
|
|
Shares |
|
|
Amount |
|
|
Paid-in Capital |
|
|
Deficit) |
|
|
Total |
|
Balance
at January 1, 2019 |
|
|
42,602,431 |
|
|
$ |
426 |
|
|
$ |
115,719 |
|
|
$ |
(46,932 |
) |
|
$ |
69,213 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options |
|
|
10,000 |
|
|
|
— |
|
|
|
9 |
|
|
|
— |
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for services |
|
|
16,129 |
|
|
|
— |
|
|
|
10 |
|
|
|
— |
|
|
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of
share-based arrangements |
|
|
— |
|
|
|
— |
|
|
|
1,819 |
|
|
|
— |
|
|
|
1,819 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(25,940 |
) |
|
|
(25,940 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
at December 31, 2019 |
|
|
42,628,560 |
|
|
$ |
426 |
|
|
$ |
117,557 |
|
|
$ |
(72,872 |
) |
|
$ |
45,111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock upon exercise of stock options |
|
|
683,613 |
|
|
|
7 |
|
|
|
56 |
|
|
|
— |
|
|
|
63 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for services |
|
|
35,714 |
|
|
|
— |
|
|
|
35 |
|
|
|
— |
|
|
|
35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of
share-based arrangements |
|
|
— |
|
|
|
— |
|
|
|
621 |
|
|
|
— |
|
|
|
621 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5,208 |
) |
|
|
(5,208 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2020 |
|
|
43,347,887 |
|
|
$ |
433 |
|
|
$ |
118,269 |
|
|
$ |
(78,080 |
) |
|
$ |
40,622 |
|
See Accompanying Notes to the Consolidated Financial
Statements.
Hudson Technologies, Inc. and Subsidiaries
Consolidated Statements of Cash
Flows
(Amounts in thousands)
|
|
For
the years ended December
31, |
|
|
|
2020 |
|
|
2019 |
|
Cash
flows from operating activities: |
|
|
|
|
|
|
|
|
Net
loss |
|
$ |
(5,208 |
) |
|
$ |
(25,940 |
) |
Adjustments
to reconcile net loss to cash provided by operating
activities: |
|
|
|
|
|
|
|
|
Depreciation |
|
|
3,234 |
|
|
|
4,185 |
|
Amortization
of intangible assets |
|
|
2,862 |
|
|
|
2,932 |
|
Gain on
insurance proceeds |
|
|
(1,000 |
) |
|
|
— |
|
Lower of
cost or net realizable value inventory adjustment |
|
|
(3,935 |
) |
|
|
(740 |
) |
Allowance
for doubtful accounts |
|
|
880 |
|
|
|
(76 |
) |
Amortization
of deferred finance cost |
|
|
1,127 |
|
|
|
2,791 |
|
Value of
share-based payment arrangements |
|
|
656 |
|
|
|
1,829 |
|
Write-off of
intangible assets |
|
|
— |
|
|
|
507 |
|
Deferred tax
expense |
|
|
163 |
|
|
|
749 |
|
Non-cash
adjustment of cylinder deposits |
|
|
— |
|
|
|
(502 |
) |
Changes
in assets and liabilities: |
|
|
|
|
|
|
|
|
Trade
accounts receivable |
|
|
(2,625
|
) |
|
|
6,080 |
|
Inventories |
|
|
18,713
|
|
|
|
43,464 |
|
Prepaid
and other assets |
|
|
(2,192 |
) |
|
|
(579 |
) |
Lease
obligations |
|
|
12 |
|
|
|
58 |
|
Income
taxes receivable/payable |
|
|
(300 |
) |
|
|
108 |
|
Accounts
payable and accrued expenses |
|
|
(700 |
) |
|
|
(1,045 |
) |
Cash
provided by operating activities |
|
|
11,687 |
|
|
|
33,821 |
|
|
|
|
|
|
|
|
|
|
Cash
flows from investing activities: |
|
|
|
|
|
|
|
|
Additions
to property, plant and equipment |
|
|
(1,470 |
) |
|
|
(1,011 |
) |
Proceeds
from insurance policy |
|
|
1,000 |
|
|
|
— |
|
Cash
used in investing activities |
|
|
(470 |
) |
|
|
(1,011 |
) |
|
|
|
|
|
|
|
|
|
Cash
flows from financing activities: |
|
|
|
|
|
|
|
|
Net
proceeds from issuances of common stock and exercises of stock
options |
|
|
63 |
|
|
|
9 |
|
Borrowing-
Paycheck Protection Program |
|
|
2,475 |
|
|
|
— |
|
Payment
of deferred financing costs |
|
|
— |
|
|
|
(1,346 |
) |
Repayment
of short-term debt – net |
|
|
(12,000 |
) |
|
|
(15,000 |
) |
Repayment
of long-term debt |
|
|
(3,007 |
) |
|
|
(16,145 |
) |
Cash
used in financing activities |
|
|
(12,469 |
) |
|
|
(32,482 |
) |
|
|
|
|
|
|
|
|
|
(Decrease) increase in cash and cash equivalents
|
|
|
(1,252 |
) |
|
|
328 |
|
Cash
and cash equivalents at beginning of period |
|
|
2,600 |
|
|
|
2,272 |
|
Cash
and cash equivalents at end of period |
|
$ |
1,348 |
|
|
$ |
2,600 |
|
|
|
|
|
|
|
|
|
|
Supplemental
disclosure of cash flow information: |
|
|
|
|
|
|
|
|
Cash
paid during period for interest |
|
$ |
11,380 |
|
|
$ |
15,162 |
|
Refund
received for income taxes- net |
|
$ |
(48 |
) |
|
$ |
(202 |
) |
See Accompanying Notes to the Consolidated Financial
Statements
Hudson Technologies, Inc. and Subsidiaries
Notes to the Consolidated Financial
Statements
Note 1 - Summary of Significant Accounting Policies
Business
Hudson Technologies, Inc., incorporated under the laws of New
York on January 11, 1991, is a refrigerant services company
providing innovative solutions to recurring problems within the
refrigeration industry. The Company’s operations consist of one
reportable segment. The Company's products and services are
primarily used in commercial air conditioning, industrial
processing and refrigeration systems, and include refrigerant and
industrial gas sales, refrigerant management services consisting
primarily of reclamation of refrigerants and RefrigerantSide®
Services performed at a customer's site, consisting of system
decontamination to remove moisture, oils and other contaminants. In
addition, the Company’s SmartEnergy OPS® service is a web-based
real time continuous monitoring service applicable to a facility’s
refrigeration systems and other energy systems. The Company’s
Chiller Chemistry® and Chill Smart® services are also predictive
and diagnostic service offerings. As a component of the Company’s
products and services, the Company also generates carbon offset
projects. The Company operates principally through its wholly-owned
subsidiary, Hudson Technologies Company, and Aspen Refrigerants
(“Aspen” or “ARI”), a division of Hudson Technologies Company.
Unless the context requires otherwise, references to the “Company”,
“Hudson”, “we", “us”, “our”, or similar pronouns refer to Hudson
Technologies, Inc. and its subsidiaries.
During the year ended December 31, 2020, the effects of a
novel strain of coronavirus ("COVID-19") pandemic and the related
actions by governments around the world to attempt to contain the
spread of the virus have materially impacted the global economy.
While it is difficult to predict the full scale of the ongoing
impact of the COVID-19 outbreak and business disruption, the
Company has been taking actions to address the impact of the
pandemic, such as working closely with our customers, reducing our
expenses and monitoring liquidity. The impact of the pandemic and
the corresponding actions were reflected into our judgments,
assumptions and estimates to prepare the financial statements. As
of the date of this filing, there has been no material impact on
our ability to procure or distribute our products and services.
However, if the duration of the COVID-19 pandemic is longer and the
operational impact is greater than estimated, the judgments,
assumptions and estimates will be updated and could result in
different results in the future.
In preparing the accompanying consolidated financial statements,
and in accordance with Accounting Standards Codification (“ASC”)
855-10 “Subsequent Events”, the Company’s management has evaluated
subsequent events through the date that the financial statements
were filed.
In the opinion of management, all estimates and adjustments
considered necessary for a fair presentation have been included and
all such adjustments were normal and recurring.
Consolidation
The consolidated financial statements, which have been prepared in
accordance with accounting principles generally accepted in the
United States, represent all companies of which Hudson directly or
indirectly has majority ownership or otherwise controls.
Significant intercompany accounts and transactions have been
eliminated. The Company's consolidated financial statements include
the accounts of wholly-owned subsidiaries Hudson
Holdings, Inc. and Hudson Technologies Company. The Company
does not present a statement of comprehensive income (loss) as its
comprehensive income (loss) is the same as its net income
(loss).
Fair Value of Financial Instruments
The carrying values of financial instruments including cash, trade
accounts receivable and accounts payable approximate fair value at
December 31, 2020 and December 31, 2019, because of the
relatively short maturity of these instruments. The carrying value
of debt approximates fair value, due to the variable rate nature of
the debt, as of December 31, 2020 and December 31, 2019.
Please see Note 2 for further details.
Credit Risk
Financial instruments, which potentially subject the Company to
concentrations of credit risk, consist principally of temporary
cash investments and trade accounts receivable. The Company
maintains its temporary cash investments in highly-rated financial
institutions and, at times, the balances exceed FDIC insurance
coverage. The Company's trade accounts receivable are primarily due
from companies throughout the United States. The Company reviews
each customer's credit history before extending credit.
The Company establishes an allowance for doubtful accounts based on
factors associated with the credit risk of specific accounts,
historical trends, and other information. The carrying value of the
Company’s accounts receivable is reduced by the established
allowance for doubtful accounts. The allowance for doubtful
accounts includes any accounts receivable balances that are
determined to be uncollectible, along with a general reserve for
the remaining accounts receivable balances. The Company adjusts its
reserves based on factors that affect the collectability of the
accounts receivable balances.
For the year ended December 31, 2020, one customer accounted
for 14% of the Company’s revenues and at December 31, 2020,
there were $2.9 million of outstanding receivables from this
customer. For the year ended December 31, 2019, one customer
accounted for 14% of the Company’s revenues and at
December 31, 2019, there were $1.8 million of outstanding
receivables from this customer.
The loss of a principal customer or a decline in the economic
prospects of and/or a reduction in purchases of the Company's
products or services by any such customer could have a material
adverse effect on the Company's operating results and financial
position.
Cash and Cash Equivalents
Temporary investments with original maturities of ninety days or
less are included in cash and cash equivalents.
Inventories
Inventories, consisting primarily of refrigerant products available
for sale, are stated at the lower of cost, on a first-in first-out
basis, or net realizable value. Where the market price of inventory
is less than the related cost, the Company may be required to write
down its inventory through a lower of cost or net realizable value
adjustment, the impact of which would be reflected in cost of sales
on the Consolidated Statements of Operations. Any such adjustment
would be based on management’s judgment regarding future demand and
market conditions and analysis of historical experience.
Property, Plant and Equipment
Property, plant and equipment are stated at cost, including
internally manufactured equipment. The cost to complete equipment
that is under construction is not considered to be material to the
Company's financial position. Provision for depreciation is
recorded (for financial reporting purposes) using the straight-line
method over the useful lives of the respective assets. Leasehold
improvements are amortized on a straight-line basis over the
shorter of economic life or terms of the respective leases. Costs
of maintenance and repairs are charged to expense when
incurred.
Due to the specialized nature of the Company's business, it is
possible that the Company's estimates of equipment useful life
periods may change in the future.
Goodwill
The Company has made acquisitions that included a significant
amount of goodwill and other intangible assets. The Company applies
the purchase method of accounting for acquisitions, which among
other things, requires the recognition of goodwill (which
represents the excess of the purchase price of the acquisition over
the fair value of the net assets acquired and identified intangible
assets). We test our goodwill for impairment on an annual basis
(the first day of the fourth quarter) and between annual tests if
an event occurs or circumstances change that would more likely than
not reduce the fair value of an asset below its carrying value.
Goodwill is tested for impairment at the reporting unit level. The
Company has one reporting unit at December 31, 2020. Other
intangible assets that meet certain criteria are amortized over
their estimated useful lives.
Beginning in 2017, the Company adopted, on a prospective basis, ASU
No. 2017-04, which simplifies the accounting for goodwill
impairment by eliminating Step 2 of the prior goodwill impairment
test that required a hypothetical purchase price allocation to
measure goodwill impairment. Under the new standard, a company will
record an impairment charge based on the excess of a reporting
unit’s carrying amount over its fair value.
An impairment charge would be recognized when the carrying amount
exceeds the estimated fair value of a reporting unit. These
impairment evaluations use many assumptions and estimates in
determining an impairment loss, including certain assumptions and
estimates related to future earnings. If the Company does not
achieve its earnings objectives, the assumptions and estimates
underlying these impairment evaluations could be adversely
affected, which could result in an asset impairment charge that
would negatively impact operating results.
In 2019, due to a significant selling price correction leading to
unfavorable market conditions, the Company performed a quantitative
test by weighing the results of an income-based valuation technique
(the discounted cash flows method) and a market-based valuation
technique, to determine the fair value of its reporting unit. The
Company also performed a similar quantitative test for its annual
impairment testing date in 2020.
The discounted cash flow methodology included: (i) management's
estimates, such as discount rates, terminal growth rates, and
projections of revenue, operating margin and cash flows and (ii)
assumptions related to general economic and market conditions,
including inherent uncertainties regarding the projected impact of
the COVID-19 pandemic. The Company initially established a forecast
of the estimated future net cash flows, which were then discounted
to their present value. The market-based valuation technique
utilizes market multiple assumptions for comparable companies to
estimate the fair value of the reporting unit.
There were no goodwill impairment losses recognized in 2019 or
2020.
Leases
In February 2016, the FASB issued Accounting Standards Update
No. 2016-02, Leases (Topic 842) (ASU 2016-02), as
amended, which generally requires lessees to recognize operating
and financing lease liabilities and corresponding right-of-use
assets on the balance sheet and to provide enhanced disclosures
surrounding the amount, timing and uncertainty of cash flows
arising from leasing arrangements. In July 2018, the FASB
issued ASU No. 2018-11, Leases – Targeted Improvements,
as an update to the previously-issued guidance. This update added a
transition option which allows for the recognition of a cumulative
effect adjustment to the opening balance of retained earnings in
the period of adoption without recasting the financial statements
in periods prior to adoption. The Company has used the modified
retrospective transition approach in ASU No. 2018-11 and
applied the new lease requirements through a cumulative-effect
adjustment in the period of adoption. The Company elected the
package of practical expedients permitted under the transition
guidance, which allows it to carryforward its historical lease
classification, its assessment on whether a contract is or contains
a lease, and its initial direct costs for any leases that existed
prior to adoption of the new standard. The Company also elected to
combine lease and non-lease components and to keep leases with an
initial term of 12 months or less off the balance sheet and
recognize the associated lease payments in the consolidated
statements of operations on a straight-line basis over the lease
term. The Company recorded approximately $8.1 million as
total right-of-use assets and total lease liabilities on its
consolidated balance sheet as of January 1, 2019. The
Company’s accounting for finance leases remained substantially
unchanged. Please see Note 6 for further details and current
balances.
Cylinder Deposit Liability
The cylinder deposit liability, which is included in Accrued
expenses and other current liabilities on the Company’s Balance
Sheet, represents the amount due to customers for the return of
refillable cylinders. ARI charges its customers cylinder
deposits upon the shipment of refrigerant gases that are contained
in refillable cylinders. The amount charged to the customer
by ARI approximates the cost of a new cylinder of the same
size. Upon return of a cylinder, this liability is
reduced. The cylinder deposit liability was assumed as part
of the ARI acquisition and the balance was $10.8 million and $9.5
million at December 31, 2020 and 2019, respectively.
Revenues and Cost of Sales
The Company’s products and services are primarily used in
commercial air conditioning, industrial processing and
refrigeration systems. Most of the Company’s revenues are realized
from the sale of refrigerant and industrial gases and related
products. The Company also generates revenue from refrigerant
management services performed at a customer’s site and in-house.
The Company conducts its business primarily within the US.
The Company applies the FASB’s guidance on revenue recognition,
which requires the Company to recognize revenue in an amount that
reflects the consideration to which the Company expects to be
entitled in exchange for goods or services transferred to its
customers. In most instances, the Company’s contract with a
customer is the customer’s purchase order and the sales price to
the customer is fixed. For certain customers, the Company may also
enter into a sales agreement outlining a framework of terms and
conditions applicable to future purchase orders received from that
customer. Because the Company’s contracts with customers are
typically for a single customer purchase order, the duration of the
contract is usually less than one year. The Company’s performance
obligations related to product sales are satisfied at a point in
time, which may occur upon shipment of the product or receipt by
the customer, depending on the terms of the arrangement. The
Company’s performance obligations related to reclamation and
RefrigerantSide® services are generally satisfied at a point in
time when the service is performed. Accordingly revenues are
recorded upon the shipment of the product, or in certain instances
upon receipt by the customer, or the completion of the service.
In July 2016 the Company was awarded, as prime contractor, a
five-year contract, including a five-year renewal option, by the
United States Defense Logistics Agency (“DLA”) for the management,
supply, and sale of refrigerants, compressed gases, cylinders and
related services. Due to the contract containing multiple
performance obligations, the Company assessed the arrangement in
accordance with ASC 606. The Company determined that the sale of
refrigerants and the management services provided under the
contract each have stand-alone value. Accordingly, the performance
obligations related to the sale of refrigerants is satisfied at a
point in time, mainly when the customer receives and obtains
control of the product. The performance obligation related to
management service revenue is satisfied over time and revenue is
recognized on a straight-line basis over the term of the
arrangement as the management services are provided.
Cost of sales is recorded based on the cost of products shipped or
services performed and related direct operating costs of the
Company’s facilities. In general, the Company performs shipping and
handling services for its customers in connection with the delivery
of refrigerant and other products. The Company elected to implement
ASC 606-10-25-18B, whereby the Company accounts for such shipping
and handling as activities to fulfill the promise to transfer the
good. To the extent that the Company charges its customers shipping
fees, such amounts are included as a component of revenue and the
corresponding costs are included as a component of cost of
sales.
The Company's revenues are derived from Product and related sales
and RefrigerantSide® Services revenues. The revenues for each of
these lines are as follows:
Years Ended December 31, |
|
2020 |
|
|
2019 |
|
(in thousands) |
|
|
|
|
|
|
|
|
Product and related sales |
|
$ |
143,210 |
|
|
$ |
157,512 |
|
RefrigerantSide
® Services |
|
|
4,395 |
|
|
|
4,547 |
|
Total |
|
$ |
147,605 |
|
|
$ |
162,059 |
|
Income Taxes
The Company is taxed at statutory corporate income tax rates after
adjusting income reported for financial statement purposes for
certain items. Current income tax expense (benefit) reflects the
tax results of revenues and expenses currently taxable or
deductible. The Company utilizes the asset and liability method of
accounting for deferred income taxes, which provides for the
recognition of deferred tax assets or liabilities, based on enacted
tax rates and laws, for the differences between the financial and
income tax reporting bases of assets and liabilities.
The tax benefit associated with the Company’s net operating loss
carry forwards (“NOLs”) is recognized to the extent that the
Company expects to realize future taxable income. As a result of a
prior “change in control”, as defined by the Internal Revenue
Service, the Company’s ability to utilize its existing NOLs is
subject to certain annual limitations. To the extent that the
Company utilizes its NOLs, it will not pay tax on such income.
However, to the extent that the Company’s net income, if any,
exceeds the annual NOL limitation, it will pay income taxes based
on the then existing statutory rates. In addition, certain states
either do not allow or limit NOLs and as such the Company will be
liable for certain state income taxes.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic
Security Act (“CARES Act”) was enacted in response to the COVID-19
pandemic. The CARES Act, among other things, permits NOL carryovers
and carrybacks to offset 100% of taxable income for taxable years
beginning before 2021. In addition, the CARES Act allows NOLs
incurred in 2018, 2019, and 2020 to be carried back to each of the
five preceding taxable years to generate a refund of previously
paid income taxes. The Company has evaluated its options
under the carryback provision and filed a claim for refund,
resulting in a cash benefit. Further, the CARES Act accelerates the
refund of the alternative minimum tax credits to allow a full
refund of any remaining credit amount in taxable years beginning in
2019. The credits were originally fully refundable in taxable years
beginning in 2021. As a result, the Company has recorded a
preliminary $47,000 tax benefit related to the alternative minimum
tax refund in the quarter ended March 31, 2020 and an
additional $380,000 in the quarter ended June 30, 2020.
Finally, the CARES Act contains modifications on the limitation of
business interest for tax years beginning in 2019 and 2020. The
modifications to Section 163(j) increase the allowable
business interest deduction from 30% of adjusted taxable income to
50% of adjusted taxable income. This modification results in a
$2,154,000 increase in allowable interest expense, which in turn
results in an increase to our net operating losses of $2,154,000 in
the year ended December 31, 2020. However, the impact of the
additional interest expense did not impact our income tax provision
since the increase in the deferred tax asset for net operating
losses was offset by an increase to the valuation allowance.
As of
December 31, 2020, the Company had NOLs of approximately $46.1
million, of which $40.7 million have no expiration date and
$5.4 million expire through 2023. As of December 31, 2020, the
Company had state tax NOLs of approximately $31.2 million expiring
in various years. We review the likelihood that we will realize the
benefit of our deferred tax assets, and therefore the need for
valuation allowances, on an annual basis in the fourth quarter of
the year, and more frequently if events indicate that a review is
required. In determining the requirement for a valuation allowance,
the historical and projected financial results are considered,
along with all other available positive and negative evidence.
Concluding that a valuation allowance is not required is difficult
when there is significant negative evidence that is objective and
verifiable, such as cumulative losses in recent years. We utilize a
rolling twelve quarters of pre-tax income or loss adjusted for
significant permanent book to tax differences, as well as
non-recurring items, as a measure of our cumulative results in
recent years. Based on our assessment as of December 31, 2019
and 2020, we concluded that due to the uncertainty that the
deferred tax assets will not be fully realized in the future, we
recorded a valuation allowance of approximately $11.3 million
during 2018, and due to additional losses, increased the valuation
allowance through 2019 and December 31, 2020, with an ending
balance of $19.0 million as of December 31, 2020.
The Company evaluates uncertain tax positions, if any, by
determining if it is more likely than not to be sustained upon
examination by the taxing authorities. As of December 31, 2020
and December 31, 2019, the Company believes it had no
uncertain tax positions.
Income per Common and Equivalent Shares
If dilutive, common equivalent shares (common shares assuming
exercise of options and warrants) utilizing the treasury stock
method are considered in the presentation of diluted earnings per
share. The reconciliation of shares used to determine net income
per share is as follows (dollars in thousands):
|
|
Years ended December 31, |
|
|
|
2020 |
|
|
2019 |
|
Net loss |
|
$ |
(5,208 |
) |
|
$ |
(25,940 |
) |
|
|
|
|
|
|
|
|
|
Weighted average number of shares – basic |
|
|
42,710,381 |
|
|
|
42,613,478 |
|
Shares underlying options |
|
|
--- |
|
|
|
--- |
|
Weighted average number of shares outstanding – diluted |
|
|
42,710,381 |
|
|
|
42,613,478 |
|
During the years ended December 31, 2020 and 2019, certain
options aggregating 5,329,515 and 7,042,377 shares, respectively,
have been excluded from the calculation of diluted shares, due to
the fact that their effect would be anti-dilutive.
Estimates and Risks
The preparation of financial statements in conformity with
generally accepted accounting principles in the United States
requires the use of estimates and assumptions that affect the
amounts reported in these financial statements and footnotes. The
Company considers these accounting estimates to be critical in the
preparation of the accompanying consolidated financial statements.
The Company uses information available at the time the estimates
are made. However, these estimates could change materially if
different information or assumptions were used including potential
impact of COVID-19 uncertainties. Additionally, these estimates may
not ultimately reflect the actual amounts of the final transactions
that occur. The Company utilizes both internal and external sources
to evaluate potential current and future liabilities for various
commitments and contingencies. In the event that the assumptions or
conditions change in the future, the estimates could differ from
the original estimates.
Several of the Company's accounting policies involve significant
judgments, uncertainties and estimates. The Company bases its
estimates on historical experience and on various other assumptions
that are believed to be reasonable under the circumstances, the
results of which form the basis for making judgments about the
carrying values of assets and liabilities. Actual results may
differ from these estimates under different assumptions or
conditions. To the extent that actual results differ from
management's judgments and estimates, there could be a material
adverse effect on the Company. On a continuous basis, the Company
evaluates its estimates, including, but not limited to, those
estimates related to its allowance for doubtful accounts, inventory
reserves, goodwill and valuation allowance for the deferred tax
assets relating to its NOLs and commitments and contingencies. With
respect to trade accounts receivable, the Company estimates the
necessary allowance for doubtful accounts based on both historical
and anticipated trends of payment history and the ability of the
customer to fulfill its obligations. For inventory, the Company
evaluates both current and anticipated sales prices of its products
to determine if a write down of inventory to net realizable value
is necessary. In determining the Company’s valuation allowance for
its deferred tax assets, the Company assesses its ability to
generate taxable income in the future.
The Company participates in an industry that is highly regulated,
and changes in the regulations affecting its business could affect
its operating results. Currently the Company purchases virgin
hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”)
refrigerants and reclaimable, primarily HCFC, HFC and
chlorofluorocarbon (“CFC”), refrigerants from suppliers and its
customers.
To the extent that the Company is unable to source sufficient
quantities of refrigerants or is unable to obtain refrigerants on
commercially reasonable terms or experiences a decline in demand
and/or price for refrigerants sold by the Company, the Company
could realize reductions in revenue from refrigerant sales, which
could have a material adverse effect on its operating results and
its financial position.
The Company is subject to various legal proceedings. The Company
assesses the merit and potential liability associated with each of
these proceedings. In addition, the Company estimates potential
liability, if any, related to these matters. To the extent that
these estimates are not accurate, or circumstances change in the
future, the Company could realize liabilities, which could have a
material adverse effect on its operating results and its financial
position.
Impairment of Long-lived Assets
The Company reviews long-lived assets for impairment whenever
events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. Recoverability of assets
to be held and used is measured by a comparison of the carrying
amount of the assets to the future net cash flows expected to be
generated by the asset. If such assets are considered to be
impaired, the impairment to be recognized is measured by the amount
by which the carrying amount of the assets exceeds the fair value
of the assets. Assets to be disposed of are reported at the lower
of the carrying amount or fair value less the cost to sell.
Recent Accounting Pronouncements
In June 2016, the FASB issued ASU
No. 2016-13, Measurement of Credit Losses on Financial
Instruments, which revises guidance for the accounting for credit
losses on financial instruments within its scope, and in
November 2018, issued ASU No. 2018-19 and in
April 2019, issued ASU No. 2019-04 and in May 2019,
issued ASU No. 2019-05, and in November 2019, issued ASU
No. 2019-11, which each amended the standard. The new standard
introduces an approach, based on expected losses, to estimate
credit losses on certain types of financial instruments and
modifies the impairment model for available-for-sale debt
securities. The new approach to estimating credit losses (referred
to as the current expected credit losses model) applies to most
financial assets measured at amortized cost and certain other
instruments, including trade and other receivables, loans,
held-to-maturity debt securities, net investments in leases and
off-balance-sheet credit exposures. This ASU is effective for
fiscal years beginning after December 15, 2022, including
interim periods within those fiscal years, with early adoption
permitted. Entities are required to apply the standard’s provisions
as a cumulative-effect adjustment to retained earnings as of the
beginning of the first reporting period in which the guidance is
adopted. The Company is still evaluating the impact of this
ASU.
In March 2020, the FASB issued ASU 2020-04, which provides
relief from accounting analysis and impacts that may otherwise be
required for modifications to agreements necessitated by reference
rate reform. It also provides optional expedients to enable the
continuance of hedge accounting where certain hedging relationships
are impacted by reference rate reform. This optional guidance is
effective immediately, and available to be used through
December 31, 2022. We are assessing the impact that reference
rate reform and the related adoption of this guidance will have on
our financial statements.
In August 2020, the FASB issued ASU 2020-06, "Debt-Debt with
Conversion and Other Options (Subtopic 470-20) and Derivatives and
Hedging-Contracts in Entity's Own Equity (Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity's
Own Equity", which is intended to simplify the accounting for
convertible instruments by removing certain separation models in
Subtopic 470-20, Debt-Debt with Conversion and Other Options, for
convertible instruments. The pronouncement is effective for fiscal
years, and for interim periods within those fiscal years, beginning
after December 15, 2021, with early adoption permitted. We are
currently in the process of evaluating the effects of the
provisions of ASU 2020-06 on our financial statements.
Note 2- Fair Value
ASC Subtopic 820-10 defines fair value as the price that would be
received to sell an asset or paid to transfer a liability in an
orderly transaction between market participants at the measurement
date. The Company often utilizes certain assumptions that market
participants would use in pricing the asset or liability, including
assumptions about risk and/or the risks inherent in the inputs to
the valuation technique. These inputs can be readily observable,
market-corroborated, or generally unobservable inputs. The Company
utilizes valuation techniques that maximize the use of observable
inputs and minimize the use of unobservable inputs. Based upon
observable inputs used in the valuation techniques, the Company is
required to provide information according to the fair value
hierarchy.
The fair value hierarchy ranks the quality and reliability of the
information used to determine fair values into three broad levels
as follows:
Level 1: Valuations for assets and liabilities traded in active
markets from readily available pricing sources for market
transactions involving identical assets or liabilities.
Level 2: Valuations for assets and liabilities traded in less
active dealer or broker markets. Valuations are obtained
from third-party pricing services for identical or similar assets
or liabilities.
Level 3: Valuations for assets and liabilities include certain
unobservable inputs in the assumptions and projections used in
determining the fair value assigned to such assets or
liabilities.
In instances where the determination of the fair value measurement
is based on inputs from different levels of the fair value
hierarchy, the level in the fair value hierarchy within which the
entire fair value measurement falls is based on the lowest level
input that is significant to the fair value measurement in its
entirety. The Company’s assessment of the significance of a
particular input to the fair value measurement in its entirety
requires judgment and considers factors specific to the asset or
liability.
Note 3 - Trade accounts receivable – net
At December 31, 2020 and 2019, trade accounts receivable are
net of reserves for doubtful accounts of $1.6 million and $0.7
million, respectively. The following table represents the activity
occurring in the reserves for doubtful accounts in 2020 and
2019.
(in thousands) |
|
|
Beginning
Balance
at January 1 |
|
|
Net additions
charged to
Operations |
|
|
Deductions
and Other |
|
|
Ending Balance
at December 31 |
|
2020 |
|
|
$ |
710 |
|
|
$ |
880 |
|
|
$ |
7 |
|
|
$ |
1,597 |
|
2019 |
|
|
$ |
1,178 |
|
|
$ |
(76 |
) |
|
$ |
(392 |
) |
|
$ |
710 |
|
Note 4- Inventories
Inventories consist of the following:
|
|
December 31,
2020 |
|
|
December 31,
2019 |
|
(in thousands) |
|
|
|
|
|
|
|
|
Refrigerants and cylinders |
|
$ |
53,593 |
|
|
$ |
72,088 |
|
Less: net realizable value adjustments |
|
|
(9,133 |
) |
|
|
(12,850 |
) |
Total |
|
$ |
44,460 |
|
|
$ |
59,238 |
|
Note 5 - Property, plant and equipment
Elements of property, plant and equipment are as follows:
December 31
, |
|
2020 |
|
|
2019 |
|
|
Estimated
Lives |
(in thousands) |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment |
|
|
|
|
|
|
|
|
|
|
- Land |
|
$ |
1,255 |
|
|
$ |
1,255 |
|
|
|
- Land improvements |
|
|
319 |
|
|
|
319 |
|
|
6-10
years |
- Buildings |
|
|
1,446 |
|
|
|
1,446 |
|
|
25-39 years |
- Building improvements |
|
|
3,072 |
|
|
|
3,045 |
|
|
25-39 years |
- Cylinders |
|
|
13,624 |
|
|
|
13,273 |
|
|
15-30 years |
- Equipment |
|
|
25,138 |
|
|
|
24,953 |
|
|
3-10
years |
- Equipment under capital lease |
|
|
315 |
|
|
|
315 |
|
|
5-7
years |
- Vehicles |
|
|
1,537 |
|
|
|
1,574 |
|
|
3-5
years |
- Lab and computer equipment, software |
|
|
3,103 |
|
|
|
3,077 |
|
|
2-8
years |
- Furniture & fixtures |
|
|
679 |
|
|
|
679 |
|
|
5-10
years |
- Leasehold improvements |
|
|
852 |
|
|
|
842 |
|
|
3-5
years |
- Equipment under construction |
|
|
944 |
|
|
|
73 |
|
|
|
Subtotal |
|
|
52,284 |
|
|
|
50,851 |
|
|
|
Accumulated depreciation |
|
|
30,374 |
|
|
|
27,177 |
|
|
|
Total |
|
$ |
21,910 |
|
|
$ |
23,674 |
|
|
|
Depreciation expense for the years ended December 31, 2020 and
2019 was $3.2 million and $4.2 million, respectively, of which $1.7
million and $2.7 million, respectively, were included as cost of
sales in the Company’s Consolidated Statements of Operations.
Note 6 - Leases
The Company has various lease agreements with terms up
to 11 years, including leases of buildings and various
equipment. Some leases include options to purchase, terminate or
extend for one or more years. These options are included in the
lease term when it is reasonably certain that the option will be
exercised.
At inception, the Company determines if an arrangement contains a
lease and whether that lease meets the classification criteria of a
finance or operating lease. Some of the Company’s lease
arrangements contain lease components (e.g. minimum rent payments)
and non-lease components (e.g. common area maintenance, charges,
utilities and property taxes). The Company elected the package of
practical expedients permitted under the transition guidance, which
allows it to carry forward its historical lease classification, its
assessment on whether a contract contains a lease, and its initial
direct costs for any leases that existed prior to the adoption of
the new standard. The Company also elected to combine lease and
non-lease components and to keep leases with an initial term of 12
months or less off the balance sheet and recognize the associated
lease payments in the consolidated statements of operations on a
straight line basis over the lease term. The Company’s lease
agreements do not contain any material residual value, guarantees
or material restrictive covenants.
Operating leases are included in Right of use asset, Accrued
expenses and other current liabilities, and Long-term lease
liabilities on the consolidated balance sheets. These assets and
liabilities are recognized at the commencement date based on the
present value of remaining lease payments over the lease term using
the Company’s secured incremental borrowing rates or implicit
rates, when readily determinable. Short-term operating leases,
which have an initial term of 12 months or less, are not recorded
on the balance sheet. Lease expense for operating leases is
recognized on a straight-line basis over the lease term. Variable
lease expense is recognized in the period in which the obligation
for those payments is incurred.
Operating lease expense of $3.0 million and $2.8 million,
for the years ended December 31, 2020 and 2019, respectively, is
included in Selling, general and administrative expenses on the
consolidated statements of operations.
The following table presents information about the amount, timing
and uncertainty of cash flows arising from the Company’s operating
leases as of December 31, 2020.
Maturity of Lease Payments |
|
December 31, 2020 |
|
(in thousands) |
|
|
|
|
-2021 |
|
|
2,282 |
|
-2022 |
|
|
1,117 |
|
-2023 |
|
|
969 |
|
-2024 |
|
|
943 |
|
-Thereafter |
|
|
2,984 |
|
Total undiscounted operating lease payments |
|
|
8,295 |
|
Less imputed interest |
|
|
(1,665 |
) |
Present value of operating lease liabilities |
|
$ |
6,630 |
|
Balance Sheet Classification
December 31
, |
|
2020 |
|
|
2019 |
|
Current lease liabilities (recorded in Accrued expenses and other
current liabilities) |
|
$ |
2,703 |
|
|
$ |
2,364 |
|
Long-term lease liabilities |
|
|
3,927 |
|
|
|
5,742 |
|
Total operating lease liabilities |
|
$ |
6,630 |
|
|
$ |
8,106 |
|
Other Information
December 31
, |
|
2020 |
|
|
2019 |
|
Weighted-average remaining term for operating leases |
|
|
4.86
years |
|
|
|
5.77
years |
|
Weighted-average discount rate for operating leases |
|
|
8.78 |
% |
|
|
8.74 |
% |
Cash Flows
Cash paid for amounts included in the present value of operating
lease liabilities for the years ended December 31, 2020 and 2019
was $3.0 million and $2.8 million and is included in
operating cash flows.
Note 7 - Income taxes
Loss
before income taxes for the years ended December 31, 2020 and 2019
was $5.4 million and $25.3 million, respectively. Income tax
expense (benefit) for the years ended December 31, 2020 and 2019
was ($0.2) million and $0.7 million, respectively. The income tax
expense for each of the years ended December 31, 2020 and 2019 was
for federal and state income tax at statutory rates applied to the
adjusted pre-tax income for each of the periods.
The following summarizes the (benefit) / provision for income
taxes:
Years Ended December 31, |
|
2020 |
|
|
2019 |
|
(in thousands) |
|
|
|
|
|
|
Current: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal |
|
$ |
(428 |
) |
|
$ |
(124 |
) |
State and local |
|
|
80 |
|
|
|
31 |
|
|
|
|
(348 |
) |
|
|
(93 |
) |
Deferred: |
|
|
|
|
|
|
|
|
Federal |
|
|
80 |
|
|
|
366 |
|
State and local |
|
|
83 |
|
|
|
383 |
|
|
|
|
163 |
|
|
|
749 |
|
(Benefit) expense for income taxes |
|
$ |
(185 |
) |
|
$ |
656 |
|
Reconciliation of the Company's actual tax rate to the U.S. Federal
statutory rate is as follows:
Years ended December 31, |
|
2020 |
|
|
2019 |
|
Income tax rates |
|
|
|
|
|
|
|
|
- Statutory U.S. federal rate |
|
|
21 |
% |
|
|
21 |
% |
- State income taxes, net of federal benefit |
|
|
0 |
% |
|
|
0 |
% |
- Excess tax benefits related to stock compensation |
|
|
0 |
% |
|
|
0 |
% |
- AMT credit and NOL Carryback
|
|
|
8 |
% |
|
|
1 |
% |
- Lobbying |
|
|
(1 |
)% |
|
|
0 |
% |
- Meals & Entertainment |
|
|
(1 |
)% |
|
|
— |
|
- Officer’s Life Insurance |
|
|
4 |
% |
|
|
0 |
% |
- Change in valuation allowance |
|
|
(28 |
)% |
|
|
(25 |
)% |
|
|
|
|
|
|
|
|
|
Total |
|
|
3 |
% |
|
|
(3 |
)% |
As of December 31, 2020, the Company had NOLs of approximately
$46.1 million, of which $40.7 million have no expiration date
(subject to annual limitations of 80% of tax earnings) and $5.4
million expire through 2023 (subject to annual limitations of
approximately $1.3 million). As of December 31, 2020, the Company
had state tax NOLs of approximately $31.2 million expiring in
various years.
Deferred income tax represents the tax effect of the differences
between the book and tax bases of assets and liabilities. The net
deferred income tax assets (liabilities) consisted of the following
at:
December
31, |
|
2020 |
|
|
2019 |
|
(in thousands) |
|
|
|
|
|
|
|
|
- Depreciation & amortization |
|
$ |
(7,424 |
) |
|
$ |
(4,899 |
) |
- Reserves for doubtful accounts |
|
|
324 |
|
|
|
163 |
|
- Inventory reserve |
|
|
1,408 |
|
|
|
2,083 |
|
- Non qualified stock options |
|
|
1,219 |
|
|
|
965 |
|
- Net operating losses |
|
|
11,963 |
|
|
|
11,016 |
|
- AMT credit |
|
|
— |
|
|
|
47 |
|
- Deferred interest |
|
|
10,114 |
|
|
|
8,351 |
|
- Deferred bonus |
|
|
74 |
|
|
|
— |
|
- Valuation allowance |
|
|
(19,033 |
) |
|
|
(18,918 |
) |
Total |
|
|
(1,355 |
) |
|
|
(1,192 |
) |
We review the likelihood that we will realize the benefit of our
deferred tax assets, and therefore the need for valuation
allowances, on an annual basis in the fourth quarter of the year,
and more frequently if events indicate that a review is required.
In determining the requirement for a valuation allowance, the
historical and projected financial results are considered, along
with all other available positive and negative evidence.
Concluding that a valuation allowance is not required is difficult
when there is significant negative evidence that is objective and
verifiable, such as cumulative losses in recent years. We utilize a
rolling twelve quarters of pre-tax income or loss adjusted for
significant permanent book to tax differences, as well as
non-recurring items, as a measure of our cumulative results in
recent years. Based on our assessment as of December 31, 2018
and 2019, we concluded that due to the uncertainty that the
deferred tax assets will not be fully realized in the future, we
recorded a valuation allowance of approximately $11.3 million
during 2018, and due to additional losses, increased the valuation
allowance through 2019 and December 31, 2020, with an ending
balance of $19.0 million as of December 31, 2020.
The Company’s 2016 and prior federal tax years have been closed.
The Company operates in many states throughout the United States
and, as of December 31, 2019, the state statutes of
limitations remain open for tax years subsequent to 2015. The
Company recognizes interest and penalties, if any, relating to
income taxes as a component of the provision for income taxes.
Note 8 – Goodwill and intangible assets
Goodwill represents the excess of the purchase price over the fair
value of the net assets acquired in business combinations accounted
for under the purchase method of accounting. In both 2019 and 2020,
due to a significant selling price correction leading to
unfavorable market conditions, the Company performed a quantitative
test by weighing the results of an income-based valuation
technique, the discounted cash flows method, and a market-based
valuation technique to determine its reporting units’ fair
values.
There were no goodwill impairment losses recognized for the years
ended December 31, 2020 and 2019. Based on the results of the
impairment assessments of goodwill and intangible assets performed,
management concluded that the fair value of the Company’s goodwill
exceeds the carrying value and that there are no impairment
indicators related to intangible assets.
At December 31, 2020 and December 31, 2019 the Company
had $47.8 million of goodwill.
The Company’s other intangible assets consist of the following:
|
|
|
|
|
2020 |
|
|
2019 |
|
|
|
Amortization |
|
|
Gross |
|
|
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
|
December 31, |
|
Period |
|
|
Carrying |
|
|
Accumulated |
|
|
|
|
|
Carrying |
|
|
Accumulated |
|
|
|
|
(in thousands) |
|
(in years) |
|
|
Amount |
|
|
Amortization |
|
|
Net |
|
|
Amount |
|
|
Amortization |
|
|
Net |
|
Intangible assets with determinable lives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patents |
|
|
5 |
|
|
$ |
386 |
|
|
$ |
386 |
|
|
$ |
— |
|
|
$ |
386 |
|
|
$ |
383 |
|
|
$ |
3 |
|
Covenant not to compete |
|
|
6 –
10 |
|
|
|
1,270 |
|
|
|
937 |
|
|
|
333 |
|
|
|
1,270 |
|
|
|
783 |
|
|
|
487 |
|
Customer relationships |
|
|
3 –
12 |
|
|
|
31,560 |
|
|
|
9,167 |
|
|
|
22,393 |
|
|
|
31,560 |
|
|
|
6,506 |
|
|
|
25,054 |
|
Above market leases |
|
|
13 |
|
|
|
567 |
|
|
|
143 |
|
|
|
424 |
|
|
|
567 |
|
|
|
99 |
|
|
|
468 |
|
Licenses |
|
|
10 |
|
|
|
1,000 |
|
|
|
1,000 |
|
|
|
— |
|
|
|
1,000 |
|
|
|
1,000 |
|
|
|
— |
|
Totals identifiable intangible assets |
|
|
|
|
|
$ |
34,783 |
|
|
$ |
11,633 |
|
|
$ |
23,150 |
|
|
$ |
34,783 |
|
|
$ |
8,771 |
|
|
$ |
26,012 |
|
The amortization of intangible assets for the years ended
December 31, 2020 and 2019, were $2.9 million and $2.9 million
respectively. Future estimated amortization expense is as follows:
2021 - $2.8 million, 2022 - $2.8 million, 2023 - $2.8 million,
2024- $2.8 million, 2025-$2.5 million and thereafter - $9.5
million.
Note 9 - Short-term and long-term debt
Elements of short-term and long-term debt are as follows:
December 31, |
|
2020 |
|
|
2019 |
|
(in thousands) |
|
|
|
|
|
|
|
|
Short-term & long-term debt |
|
|
|
|
|
|
|
|
Short-term debt: |
|
|
|
|
|
|
|
|
- Revolving credit line and other debt |
|
$ |
2,000 |
|
|
$ |
14,000 |
|
-
Loan from Paycheck Protection Program- current |
|
|
2,062 |
|
|
|
- |
|
-
Capital lease obligation- current |
|
|
4 |
|
|
|
- |
|
- Term loan facility - current |
|
|
5,248 |
|
|
|
3,008 |
|
Subtotal |
|
|
9,314 |
|
|
|
17,008 |
|
Long-term debt: |
|
|
|
|
|
|
|
|
- Term loan facility- net of current portion of long-term
debt
|
|
|
79,867 |
|
|
|
85,115 |
|
-
Loan from Paycheck Protection Program- net of current portion |
|
|
413 |
|
|
|
- |
|
-
Capital lease obligations |
|
|
- |
|
|
|
3 |
|
- Less: deferred financing costs on term loan |
|
|
(2,304 |
) |
|
|
(3,136 |
) |
Subtotal |
|
|
77,976 |
|
|
|
81,982 |
|
|
|
|
|
|
|
|
|
|
Total short-term & long-term debt |
|
$ |
87,290 |
|
|
$ |
98,990 |
|
Revolving Credit Facility
On December 19, 2019, Hudson Technologies Company (“HTC”),
Hudson Holdings, Inc. (“Holdings”) and Aspen
Refrigerants, Inc. (“ARI”), as borrowers (collectively, the
“Borrowers”), and Hudson Technologies, Inc. (the “Company”) as
a guarantor, became obligated under a Credit Agreement (the “Wells
Fargo Facility”) with Wells Fargo Bank, as administrative agent and
lender (“Agent” or “Wells Fargo”) and such other lenders as may
thereafter become a party to the Wells Fargo Facility.
Under the terms of the Wells Fargo Facility, the Borrowers may
borrow, from time to time, up to $60 million at any time consisting
of revolving loans in a maximum amount up to the lesser of $60
million and a borrowing base that is calculated based on the
outstanding amount of the Borrowers’ eligible receivables and
eligible inventory, as described in the Wells Fargo Facility. The
Wells Fargo Facility also contains a sublimit of $5 million for
swing line loans and $2 million for letters of credit.
Amounts borrowed under the Wells Fargo Facility were used by the
Borrowers to repay existing revolving indebtedness under its prior
revolving credit facility, repay certain principal amounts under
the Term Loan Facility (as defined below), and may be used for
working capital needs, certain permitted acquisitions, and to
reimburse drawings under letters of credit.
Interest on loans under the Wells Fargo Facility is payable in
arrears on the first day of each month. Interest charges with
respect to loans are computed on the actual principal amount of
loans outstanding during the month at a rate per annum equal to
(A) with respect to Base Rate loans, the sum of (i) a
rate per annum equal to the higher of (1) the federal funds
rate plus 0.5%, (2) one month LIBOR plus 1.0%, and
(3) the prime commercial lending rate of Wells Fargo, plus
(ii) between 1.25% and 1.75% depending on average monthly
undrawn availability and (B) with respect to LIBOR rate loans,
the sum of the LIBOR rate plus between 2.25% and 2.75% depending on
average monthly undrawn availability.
In connection with the closing of the Wells Fargo Facility, the
Company also entered into a Guaranty and Security Agreement, dated
as of December 19, 2019 (the “Revolver Guaranty and Security
Agreement”), pursuant to which the Company and certain subsidiaries
unconditionally guaranteed the payment and performance of all
obligations owing by Borrowers to Wells Fargo, as Agent for the
benefit of the revolving lenders. Pursuant to the Revolver Guaranty
and Security Agreement, Borrowers, the Company and ten other
subsidiaries granted to the Agent, for the benefit of the Wells
Fargo Facility lenders, a security interest in substantially all of
their respective assets, including receivables, equipment, general
intangibles (including intellectual property), inventory,
subsidiary stock, real property, and certain other assets. The
Revolver Guaranty and Security Agreement also provides that the
Agent shall receive the right to dominion over certain of the
Borrowers’ bank accounts in the event of an Event of Default under
the Wells Fargo Facility, or if undrawn availability under the
Wells Fargo Facility falls below $9 million at any time.
The Wells Fargo Facility contains a financial covenant requiring
the Company to maintain at all times minimum liquidity (defined as
availability under the Wells Fargo Facility plus unrestricted cash)
of at least $5 million, of which at least $3 million must be
derived from availability. The Wells Fargo Facility also contains a
springing covenant, which takes effect only upon a failure to
maintain undrawn availability of at least $7.5 million, requiring
the Company to maintain a Fixed Charge Coverage Ratio (FCCR) of not
less than 1.00 to 1.00, as of the end of each trailing period of
twelve consecutive fiscal months commencing with the month prior to
the triggering of the covenant. The FCCR (as defined in the Wells
Fargo Facility) is the ratio of (a) EBITDA for such period,
minus unfinanced capital expenditures made during such period, to
(b) the aggregate amount of (i) interest expense required
to be paid (other than interest paid-in-kind, amortization of
financing fees, and other non-cash interest expense) during such
period, (ii) scheduled principal payments (but excluding
principal payments relating to outstanding revolving loans under
the Wells Fargo Facility), (iii) all net federal, state, and
local income taxes required to be paid during such period
(provided, that any tax refunds received shall be applied to the
period in which the cash outlay for such taxes was made),
(iv) all restricted payments paid (as defined in the Wells
Fargo Facility) during such period, and (v) to the extent not
otherwise deducted from EBITDA for such period, all payments
required to be made during such period in respect of any funding
deficiency or funding shortfall with respect to any pension plan.
The FCCR covenant ceases after the Borrowers have been in
compliance therewith for two consecutive months.
The Wells Fargo Facility also contains customary non-financial
covenants relating to the Company and the Borrowers, including
limitations on Borrowers’ ability to pay dividends on common stock
or preferred stock, and also includes certain events of default,
including payment defaults, breaches of representations and
warranties, covenant defaults, cross-defaults to other obligations,
events of bankruptcy and insolvency, certain ERISA events,
judgments in excess of specified amounts, impairments to guarantees
and a change of control. The Wells Fargo Facility also contains
certain covenants contained in the Fourth Amendment to the Term
Loan Facility described below.
On April 23, 2020, the Borrowers, the Company and its
subsidiaries entered into a First Amendment to Credit Agreement
with Wells Fargo (the “First Amendment”). The First Amendment
authorized the Company and its subsidiaries to incur up to $2.5
million of indebtedness under the Coronavirus Aid, Relief, and
Economic Security Act (the “CARES Act”) and contained other
provisions relating to the treatment of such proceeds and any
potential debt forgiveness, under the Wells Fargo Facility.
The commitments under the Wells Fargo Facility will expire and the
full outstanding principal amount of the loans, together with
accrued and unpaid interest, are due and payable in full on
December 19, 2022, unless the commitments are terminated and
the outstanding principal amount of the loans are accelerated
sooner following an event of default.
Term Loan Facility
On October 10, 2017, HTC, Holdings, and ARI, as borrowers, and
the Company, as guarantor, became obligated under a Term Loan
Credit and Security Agreement (as amended, the “Term Loan
Facility”) with U.S. Bank National Association, as administrative
agent and collateral agent (“Term Loan Agent”) and funds
advised by FS Investments and such other lenders as may thereafter
become a party to the Term Loan Facility (the “Term Loan
Lenders”).
Under the terms of the Term Loan Facility, the Borrowers
immediately borrowed $105 million pursuant to a term loan (the
“Term Loan”).
The Term Loan matures on October 10, 2023. Interest on the
Term Loan is generally payable on the earlier of the last day
of the interest period applicable to such Eurodollar rate loan and
the last day of the Term Loan Facility, as applicable. Interest is
payable at the rate per annum of the Eurodollar Rate (as defined in
the Term Loan Facility) plus 10.25%. The Borrowers have the
option of paying 3.00% interest per annum in kind by adding such
amount to the principal of the Term Loans during no more than five
fiscal quarters during the term of the Term Loan Facility.
Borrowers and the Company granted to the Term Loan Agent, for the
benefit of the Term Loan Lenders, a security interest in
substantially all of their respective assets, including
receivables, equipment, general intangibles (including intellectual
property), inventory, subsidiary stock, real property, and certain
other assets.
The Term Loan Facility contains a financial covenant requiring the
Company to maintain a specified total leverage ratio (“TLR”),
tested as of the last day of the fiscal quarter. The TLR (as
defined in the Term Loan Facility) is the ratio of (a) funded
debt as of such day to (b) EBITDA for the four consecutive
fiscal quarters ending on the last day of such fiscal quarter.
Funded debt (as defined in the Term Loan Facility) includes amounts
borrowed under the Wells Fargo Facility and the Term Loan Facility
as well as capitalized lease obligations and other indebtedness for
borrowed money maturing more than one year from the date of
creation thereof. As of December 31, 2020 and 2019, the TLR was
approximately 5.84 to 1 and 11.22 to 1, respectively.
The Term Loan Facility also contains customary non-financial
covenants relating to the Company and the Borrowers, including
limitations on their ability to pay dividends on common stock or
preferred stock, and also includes certain events of default,
including payment defaults, breaches of representations and
warranties, covenant defaults, cross-defaults to other obligations,
events of bankruptcy and insolvency, certain ERISA events,
judgments in excess of specified amounts, impairments to guarantees
and a change of control.
In connection with the closing of the Term Loan Facility, the
Company also entered into a Guaranty and Suretyship Agreement,
dated as of October 10, 2017 (the “Term Loan Guarantee”),
pursuant to which the Company affirmed its unconditional guarantee
of the payment and performance of all obligations owing by
Borrowers to Term Loan Agent, as agent for the benefit of the Term
Loan Lenders.
The Term Loan Agent and the Agent have entered into an
intercreditor agreement governing the relative priority of their
security interests granted by the Borrowers and the Guarantor in
the collateral, providing that the Agent shall have a first
priority security interest in the accounts receivable, inventory,
deposit accounts and certain other assets (the “Revolving Credit
Priority Collateral”) and the Term Loan Agent shall have a first
priority security interest in the equipment, real property, capital
stock of subsidiaries and certain other assets (the “Term Loan
Priority Collateral”).
On December 19, 2019, HTC, Holdings and ARI as borrowers and
the Company as a guarantor, entered into a Waiver and Fourth
Amendment to Term Loan Credit and Security Agreement (the “Fourth
Amendment”) with U.S. Bank National Association, as collateral
agent and administrative agent, and the various lenders
thereunder.
The Fourth Amendment waived financial covenant defaults at
June 30, 2019 and September 30, 2019 and amended the Term
Loan Credit and Security Agreement dated October 10, 2017 (as
previously amended, the “Term Loan Facility”) to reset the maximum
Total Leverage Ratio covenant contained in the Term Loan Facility
at the indicated dates as follows: (i) September 30, 2019
- 15.67:1.00; (ii) December 31, 2019 – 14.54:1.00;
(iii) March 31, 2020 – 16.57:1.00;
(iv) June 30, 2020 – 10.87:1.00;
(v) September 30, 2020 – 8.89:1.00;
(vi) December 31, 2020 – 8.89:1.00;
(vii) March 31, 2021 – 7.75:1.00;
(viii) June 30, 2021 – 7.03:1.00;
(ix) September 30, 2021 – 6.08:1.00; and
(x) December 31, 2021 – 5.36:1.00. The Fourth Amendment
also reset the minimum liquidity requirement (consisting of cash
plus undrawn availability on the Borrowers’ revolving loan
facility) of $5 million, measured monthly. Furthermore, the Fourth
Amendment added a minimum LTM Adjusted EBITDA covenant as of the
indicated dates as follows: (i) September 30, 2019 -
$7.887 million; (ii) December 31, 2019 – $7.954 million;
(iii) March 31, 2020 – $7.359 million;
(iv) June 30, 2020 – $11.745 million;
(v) September 30, 2020 – $12.021 million;
(vi) December 31, 2020 – $12.300 million;
(vii) March 31, 2021 –$14.295 million;
(viii) June 30, 2021 – $14.566 million;
(ix) September 30, 2021 – $15.431 million; and
(x) December 31, 2021 – $16.267 million.
The Fourth Amendment also (i) continues the limitation on
acquisitions and dividends, (ii) required a principal
repayment of $14,000,000 upon execution of the Fourth Amendment and
(iii) increases the scheduled quarterly principal repayments
to $562,000 effective March 31, 2020 and $1,312,000 effective
December 31, 2020.
The Fourth Amendment also terminated the exit fee payable to the
term loan lenders, which would have been payable in full in cash
upon the earlier to occur of (x) repayment in full of the term
loans, or (y) any acceleration of the term loans. In lieu of
the exit fee, the Fourth Amendment reinstated a prepayment premium
equal to the following percentages of the principal amount prepaid,
depending upon the date of prepayment: (i) through
March 31, 2020 – 0.50%; (ii) from April 1, 2020
through March 31, 2021 – 2.50%; and (iii) from
April 1, 2021 and thereafter – 5.00%.
The Fourth Amendment also added a new covenant providing that in
the event of a breach of a financial covenant contained in the Term
Loan Facility or any failure to make a required principal repayment
(a “Trigger Event”), then on or prior to six months after a Trigger
Event, the Company shall commence a process to (x) sell its
businesses and/or assets, and/or (y) consummate a refinancing
transaction with respect to the Term Loan Facility (a
“Transaction”), in each case, subject to enumerated time milestones
contained in the Fourth Amendment, and which requires that
Transaction shall, in any event, be consummated on or prior to the
eighteen (18) month anniversary of the Trigger Event.
As closing conditions to the execution and delivery of the Fourth
Amendment, the Company was required to: (i) amend its Bylaws
in a manner acceptable to the Term Loan Facility lenders;
(ii) appoint two new independent directors to the board of
directors (the “Special Directors”); and (iii) pay an
amendment fee of 0.50% of the amount of the outstanding loans under
the Term Loan Facility.
On April 23, 2020, HTC, Holdings and ARI as borrowers and the
Company as a guarantor, entered into a Fifth Amendment to Term Loan
Credit and Security Agreement (the “Fifth Amendment”) with U.S.
Bank National Association, as collateral agent and administrative
agent, and the various lenders thereunder. The Fifth Amendment
authorized the Company and its subsidiaries to incur up to $2.5
million of indebtedness under the CARES Act and contained other
provisions relating to the treatment of such proceeds and any
potential debt forgiveness, under the Term Loan Facility.
The Company evaluated the Fourth and Fifth Amendments in accordance
with the provisions of Accounting Standards Codification (“ASC”)
470, Debt, to determine if the Amendments were (1) a troubled
debt restructuring, and if not, (2) a modification or an
extinguishment of debt. The Company concluded that the Fourth
Amendment was a troubled debt restructuring for accounting purposes
due to the removal of the exit fee; as such, the Company
capitalized an additional $0.5 million of deferred financing costs,
which are being amortized over the remaining term. The future
undiscounted cash flows of the term loan, as amended, exceeded the
carrying value, and accordingly, no gain was recognized and no
adjustment was made to the carrying value of the debt.
The Company was in compliance with all covenants, under the Wells
Fargo Facility and the Term Loan Facility, as amended, as of
December 31, 2020.
The Company’s ability to comply with these covenants in future
quarters may be affected by events beyond the Company’s control,
including general economic conditions, weather conditions,
regulations and refrigerant pricing. Therefore, we cannot make any
assurance that we will continue to be in compliance during future
periods.
The Company believes that it will be able to satisfy its working
capital requirements for the foreseeable future from anticipated
cash flows from operations and available funds under the Wells
Fargo Facility. Any unanticipated expenses, including, but not
limited to, an increase in the cost of refrigerants purchased by
the Company, an increase in operating expenses or failure to
achieve expected revenues from the Company’s RefrigerantSide®
Services and/or refrigerant sales or additional expansion or
acquisition costs that may arise in the future would adversely
affect the Company’s future capital needs. There can be no
assurance that the Company’s proposed or future plans will be
successful, and as such, the Company may require additional capital
sooner than anticipated, which capital may not be available on
acceptable terms, or at all.
CARES Act Loan
On April 23, 2020 the Company received a loan in the amount of
$2.475 million from Meridian Bank under the Paycheck Protection
Program (“PPP”) pursuant to the CARES Act. The loan has a term of
two years, is unsecured, and bears interest at a fixed rate of one
percent per annum, with the first six months of principal and
interest deferred. As a result of the COVID-19 pandemic, in
applying for the loan the Company made a good faith assertion based
upon the degree of uncertainty introduced to the capital markets
and the industries affecting the Company's customers and the
Company's dependency to curtail expenses to fund ongoing
operations. The PPP loan proceeds have been used in part to
help offset payroll costs as stipulated in the legislation. All or
a portion of the PPP loan may be forgiven by the U.S. Small
Business Administration (“SBA”) upon application by the Company and
upon documentation of expenditures in accordance with the SBA
requirements. Under the CARES Act, loan forgiveness is available
for the sum of documented payroll costs and other covered areas,
such as rent payments, mortgage interest and utilities, as
applicable. The Company has applied for loan forgiveness and
intends to comply with the loan forgiveness provisions in the
legislation, however, there are no assurances that the Company will
obtain full forgiveness of the loan based on current
guidelines.
Vehicle and Equipment Loans
The Company has from time to time entered into various vehicle and
equipment loans. These loans were payable in 60 monthly payments
through June 2020 and bore interest ranging from 0.0% to 8.3%.
All such loans have been repaid in full at December 31,
2020.
Capital Lease Obligations
The Company rents certain equipment with a de minimis net book
value at December 31, 2020 under leases which have been
classified as capital leases.
Scheduled maturities of the Company's long-term debt and capital
lease obligations are as follows:
Years ended December 31, |
|
|
Amount |
|
(in
thousands) |
|
|
|
|
|
-2021 |
|
|
$ |
5,251 |
|
-2022 |
|
|
|
5,248 |
|
-2023 |
|
|
|
74,620 |
|
-2024 |
|
|
|
-- |
|
-2025 |
|
|
|
-- |
|
Thereafter |
|
|
|
-- |
|
Total |
|
|
$ |
85,119 |
|
Note 10 - Commitments and contingencies
Rents and operating leases
The Company utilizes leased facilities and operates equipment under
non-cancelable operating leases through July 2030. Below is a
table of key properties:
Properties
Location |
|
Annual
Rent |
|
|
Lease
Expiration
Date |
Auburn, Washington |
|
$ |
60,000 |
|
|
|
Month
to Month |
Baton
Rouge, Louisiana |
|
$ |
24,600 |
|
|
|
Month
to Month |
Champaign, Illinois |
|
$ |
654,000 |
|
|
|
12/2024 |
Champaign, Illinois
(2nd location) |
|
$ |
305,000 |
|
|
|
9/2021 |
Charlotte, North Carolina |
|
$ |
31,000 |
|
|
|
5/2021 |
Escondido, California |
|
$ |
219,000 |
|
|
|
6/2022 |
Hampstead, New Hampshire |
|
$ |
33,000 |
|
|
|
8/2022 |
Long
Beach, California |
|
$ |
27,600 |
|
|
|
2/2022 |
Long
Island City, New York |
|
$ |
815,000 |
|
|
|
7/2021 |
Ontario, California |
|
$ |
110,400 |
|
|
|
12/2021 |
Pearl
River, New York |
|
$ |
150,000 |
|
|
|
12/2021 |
Riverside, California |
|
$ |
27,000 |
|
|
|
Month
to Month |
Rantoul, Illinois |
|
$ |
36,000 |
|
|
|
2/2021 |
Smyrna, Georgia |
|
$ |
465,000 |
|
|
|
7/2030 |
Stony
Point, New York |
|
$ |
105,000 |
|
|
|
6/2021 |
The Company rents properties and various equipment under operating
leases. Operating lease expense for the years ended
December 31, 2020 and 2019 totaled approximately $3.0 million
and $2.8 million. In addition to the properties above, the Company
does at times utilize public warehouse space on a month to month
basis. The Company typically enters into short-term leases for the
facilities and wherever possible extends the expiration date of
such leases.
Note 11 - Share-Based Compensation
Share-based compensation represents the cost related to share-based
awards, typically stock options or stock grants, granted to
employees, non-employees, officers and directors. Share-based
compensation is measured at grant date, based on the estimated
aggregate fair value of the award on the grant date, and such
amount is charged to compensation expense on a straight-line basis
over the requisite service period. For the years ended
December 31, 2020 and 2019, the share-based compensation
expense of $0.7 million and $1.8 million, respectively, is
reflected in General and administrative expenses in the
consolidated Statements of Operations.
Share-based awards have historically been made as stock options,
and recently also as stock grants, issued pursuant to the terms of
the Company’s stock option and stock incentive plans,
(collectively, the “Plans”), described below. The Plans may be
administered by the Board of Directors or the Compensation
Committee of the Board or by another committee appointed by the
Board from among its members as provided in the Plans. Presently,
the Plans are administered by the Company’s Compensation Committee
of the Board of Directors. As of December 31, 2020 there were
4,070,936 shares of the Company’s common stock available under the
Plans for issuance for future stock option grants or other stock
based awards.
Stock option awards, which allow the recipient to purchase shares
of the Company’s common stock at a fixed price, are typically
granted at an exercise price equal to the Company’s stock price at
the date of grant. Typically, the Company’s stock option awards
have vested from immediately to two years from the grant date and
have had a contractual term ranging from three to ten years.
ISOs granted under the Plans may not be granted at a price less
than the fair market value of the common stock on the date of grant
(or 110% of fair market value in the case of persons holding 10% or
more of the voting stock of the Company). Nonqualified options
granted under the Plans may not be granted at a price less than the
fair market value of the common stock. Options granted under the
Plans expire not more than ten years from the date of grant (five
years in the case of ISOs granted to persons holding 10% or more of
the voting stock of the Company).
Effective September 17, 2014, the Company adopted its 2014
Stock Incentive Plan (“2014 Plan”) pursuant to which 3,000,000
shares of common stock were reserved for issuance (i) upon the
exercise of options, designated as either ISOs under the Code or
nonqualified options, or (ii) as stock, deferred stock or
other stock-based awards. ISOs may be granted under the 2014 Plan
to employees and officers of the Company. Non-qualified options,
stock, deferred stock or other stock-based awards may be granted to
consultants, directors (whether or not they are employees),
employees or officers of the Company. Stock appreciation rights may
also be issued in tandem with stock options. Unless the 2014 Plan
is sooner terminated, the ability to grant options or other awards
under the 2014 Plan will expire on September 17, 2024.
Effective June 7, 2018, the Company adopted its 2018 Stock
Incentive Plan (“2018 Plan”) pursuant to which 4,000,000 shares of
common stock were reserved for issuance (i) upon the exercise
of options, designated as either ISOs under the Code or
nonqualified options, or (ii) as stock, deferred stock or
other stock-based awards. ISOs may be granted under the 2018 Plan
to employees and officers of the Company. Non-qualified options,
stock, deferred stock or other stock-based awards may be granted to
consultants, directors (whether or not they are employees),
employees or officers of the Company. Stock appreciation rights may
also be issued in tandem with stock options. Unless the 2018 Plan
is sooner terminated, the ability to grant options or other awards
under the 2018 Plan will expire on June 7, 2028.
Effective June 11, 2020, the Company adopted its 2020 Stock
Incentive Plan (“2020 Plan”) pursuant to which 3,000,000 shares of
common stock were reserved for issuance (i) upon the exercise
of options, designated as either ISOs under the Code or
nonqualified options, or (ii) as stock, deferred stock or
other stock-based awards. ISOs may be granted under the 2020 Plan
to employees and officers of the Company. Non-qualified options,
stock, deferred stock or other stock-based awards may be granted to
consultants, directors (whether or not they are employees),
employees or officers of the Company. Stock appreciation rights may
also be issued in tandem with stock options. Unless the 2020 Plan
is sooner terminated, the ability to grant options or other awards
under the 2020 Plan will expire on June 11, 2030.
All stock options have been granted to employees and non-employees
at exercise prices equal to or in excess of the market value on the
date of the grant.
The Company determines the fair value of share based awards at the
grant date by using the Black-Scholes option-pricing model, and has
utilized the “simplified” method, as prescribed by the SEC’s Staff
Accounting Bulletin (“SAB”) No.110, Share-Based Payment, to compute
expected lives of share based awards with the following
weighted-average assumptions:
Years ended
December 31, |
|
2020 |
|
|
|
2019 |
|
|
Assumptions |
|
|
|
|
|
|
|
|
|
|
Dividend yield |
|
|
0 |
% |
|
|
|
0 |
% |
|
Risk free interest rate |
|
|
0.27%-0.29 |
% |
|
|
|
1.43%-2.47 |
% |
|
Expected volatility |
|
|
101%-103 |
% |
|
|
|
65%-76 |
% |
|
Expected lives |
|
|
2.75-5
years |
|
|
|
|
3-5
years |
|
|
A summary of the activity for the Company's Plans for the indicated
periods is presented below:
Stock Option Plan Totals |
|
Shares |
|
|
Weighted
Average
Exercise Price |
|
Outstanding at December 31, 2018 |
|
|
4,415,397 |
|
|
$ |
1.20 |
|
-Cancelled |
|
|
(527,820 |
) |
|
$ |
1.23 |
|
-Exercised |
|
|
(10,000 |
) |
|
$ |
0.89 |
|
-Granted |
|
|
3,164,800 |
|
|
$ |
0.79 |
|
Outstanding at December 31, 2019 |
|
|
7,042,377 |
|
|
$ |
1.01 |
|
-Cancelled |
|
|
-- |
|
|
$ |
-- |
|
-Exercised |
|
|
(1,967,562 |
) |
|
$ |
0.91 |
|
-Granted |
|
|
254,700 |
|
|
$ |
1.11 |
|
Outstanding at December 31, 2020 |
|
|
5,329,515 |
|
|
$ |
1.06 |
|
Options to purchase 254,700 shares were granted in 2020, of which
187,132 shares vested in 2020, and 67,568 will vest in 2021.
The following is the weighted average contractual life in years and
the weighted average exercise price at December 31, 2020 and
2019 of:
|
|
Number of |
|
|
Weighted
Average
Remaining
Contractual |
|
|
Weighted
Average |
|
December 31, 2020 |
|
Options |
|
|
Life |
|
|
Exercise Price |
|
Options outstanding |
|
|
5,329,515 |
|
|
|
3.55 |
|
|
$ |
1.06 |
|
Options vested |
|
|
5,261,947 |
|
|
|
3.54 |
|
|
$ |
1.05 |
|
Options unvested |
|
|
67,568 |
|
|
|
4.71 |
|
|
$ |
1.23 |
|
|
|
Number of |
|
|
Weighted
Average
Remaining
Contractual |
|
|
Weighted
Average |
|
December 31, 2019 |
|
Options |
|
|
Life |
|
|
Exercise Price |
|
Options outstanding |
|
|
7,042,377 |
|
|
|
5.0
years |
|
|
$ |
1.01 |
|
Options vested |
|
|
5,922,377 |
|
|
|
4.0
years |
|
|
$ |
1.06 |
|
Options unvested |
|
|
1,120,000 |
|
|
|
10.0
years |
|
|
$ |
0.75 |
|
The intrinsic values of options outstanding at December 31,
2020 and 2019 are $0.7 million and $0.7 million, respectively.
The intrinsic value of options unvested at December 31, 2020
and 2019 are $0.0 million and $0.3 million, respectively.
The intrinsic values of options vested and exercised during the
years ended 2020 and 2019 were as follows:
|
|
|
2020 |
|
|
2019 |
|
Intrinsic
value of options vested |
|
|
$ |
393,952 |
|
|
$ |
436,000 |
|
Intrinsic
value of options exercised |
|
|
$ |
843,893 |
|
|
$ |
11,100 |
|
Note 12 – Other income
On June 23, 2020, Kevin J. Zugibe, Chairman of the Board and
Chief Executive Officer of the Company, passed away unexpectedly.
During the third quarter of 2020, the Company received $1 million
of key man life insurance proceeds and accordingly recorded the
amount as Other income in its Consolidated Statement of
Operations.
In August 2019, the Company received $8.9 million of cash pursuant
to the settlement of a working capital adjustment dispute arising
from the acquisition of Aspen Refrigerants, Inc. in October 2017.
In addition, during the second quarter of 2019, the Company
recorded approximately $0.5 million of Other income relating to a
change in estimate of its cylinder deposit liability account.
Note 13 – Related Party Transactions
Stephen P. Mandracchia served as Vice President – Legal and
Regulatory and Secretary of the Company through May 3, 2019
and since that date served the Company in a consulting role through
August 31, 2020. From May 6, 2019 through
December 31, 2019, Mr. Mandracchia received a monthly
consulting fee of $10,000 and such fee was increased to $12,000 per
month effective January 1, 2020. During the period
January 1, 2019 through May 3, 2019, Mr. Mandracchia
was paid base salary of $94,656 and was issued a stock option to
purchase 25,000 shares of Company common stock at an exercise price
of $1.70 per share. Mr. Mandracchia is the brother-in-law of
Kevin J. Zugibe, the Company’s former Chairman of the Board and
Chief Executive Officer. Effective September 1, 2020,
Mr. Mandracchia became a member of the Company’s Board of
Directors.
SIGNATURES
Pursuant to the requirements of Section 13 or 15 (d) of
the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
HUDSON TECHNOLOGIES, INC.
By: |
/s/
Brian F. Coleman |
|
|
Brian
F. Coleman, Chairman and Chief Executive Officer |
|
|
|
|
Date: |
March 12,
2021 |
|
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons on
behalf of the registrant and in the capacities and on the dates
indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/
Brian F. Coleman |
|
Chairman of the Board, President and Chief Executive Officer
(Principal Executive Officer)
|
|
March 12,
2021 |
Brian
F. Coleman |
|
|
|
|
|
|
|
|
|
/s/
Nat Krishnamurti |
|
Chief
Financial Officer (Principal Financial and Accounting
Officer) |
|
March 12,
2021 |
Nat
Krishnamurti |
|
|
|
|
|
|
|
|
|
/s/
Vincent P. Abbatecola |
|
Director |
|
March 12,
2021 |
Vincent
P. Abbatecola |
|
|
|
|
|
|
|
|
|
/s/
Richard D. Caruso |
|
Director |
|
March 12,
2021 |
Richard
D. Caruso |
|
|
|
|
|
|
|
|
|
/s/
Jill K. Frizzley |
|
Director |
|
March 12,
2021 |
Jill
K. Frizzley |
|
|
|
|
|
|
|
|
|
/s/
Stephen P. Mandracchia |
|
Director |
|
March 12,
2021 |
Stephen
P. Mandracchia |
|
|
|
|
|
|
|
|
|
/s/
Dominic J. Monetta |
|
Director |
|
March 12,
2021 |
Dominic
J. Monetta |
|
|
|
|
|
|
|
|
|
/s/
Otto C. Morch |
|
Director |
|
March 12,
2021 |
Otto
C. Morch |
|
|
|
|
|
|
|
|
|
/s/
Richard Parrillo |
|
Director |
|
March 12,
2021 |
Richard
Parrillo |
|
|
|
|
|
|
|
|
|
/s/
Eric A. Prouty |
|
Director |
|
March 12,
2021 |
Eric
A. Prouty |
|
|
|
|